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The Great, Global Promise of Genetically
Modified Organisms: Overcoming Fear,
Misconceptions, and the Cartagena Protocol on
Biosafety
KURT BUECHLE*
INTRODUCTION
Modem biotechnology holds the key to solving many global environmental
and health problems, including the need for sustainable development.' Globally,
the acreage of transgenic crops has increased twenty-five fold over the five-year
period of 1996 to 2000.2 The total global acreage for 2000 is estimated to have
been 109.2 million acres, nearly twice the size of Great Britain.3 Biotechnology
has been used for twenty-five years with periodic scrutiny and risk evaluation,
and there has been no evidence of harm caused by its application.4 Nevertheless,
release and spread of any organism in a non-native environment is an important
issue of global concern. Consequences that novel organisms may have on human
health are also valid concerns. Unfortunately, there is no shortage of pessimists
and activists who seek to severely limit or ban all genetically-modified products. 5
* J.D. Candidate, December 2001, Indiana University School of Law, Bloomington. The author dedicates
this note to his parents. The author also wishes to thank Professor John Applegate for many helpful discussions
and his assistance in revising this note.
I. See NAT'L. ACAD. OF Sci., TRANSGENIC PLANTS AND WORLD AGRICULTURE 6 (2000), available at
http://bob.nap.edu/html/transgenic; see. eg., John Wall, A Plague Upon the Land: Plum Pox Virus Threatens
Pennsylvania's Fruit Industry, PENN ST. AGRIC, Summer/Fall 2000, at 9, 15 (explaining that genetic engineering
is the long term solution to protecting fruit trees from the plum pox virus); William H. R. Langridge, Edible
Vaccines, SC. AM., Sept. 2000, at 66.
2. CLIVE JAMES, INT'L SERV. FOR THE ACQUISITION OF AGRI-BIOTECH APPLICATIONS [ISAAA], BItffNb.21:
2000 PREVIEW, GLOBAL STATUS OF COMMERCIALIZED TRANSGENIC CROPS: 2000 (2000), available at
http://www.isaaa.orgIpublications/briefs/Brief_21 .htn.
3. Id. By the end of 2001, total acreage globally for genetically modified crops is expected to be 125 acres.
Press Release, Global GM Crops Area Continues to Grow-Likely to Reach 50 Million Hectares, or 125 Million
Acres, in 2001 (Oct. 18, 2001), at http://www.isaaa.org/press%20release/
Global%20GMC%2OArea.htm.
4. Julian Kinderlerer, Genetically Modified Organisms: A European Scientist's View, 8 N.Y.U. ENVrL.U.
556, 560-61 (2000).
5. See Norman Borlaug, We Need Biotech to Feed the World, WALL ST. J., Dec. 6, 2000, at A22; Ronald
Bailey, Dr. Strangelunch Or: Why We Should Learn to Stop Worrying and Love Genetically Modified Food,
REASON, Jan. 2001, available at http://reason.com/010I/fe.rb.dr.html.
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The Cartagena Protocol on Biosafety (Protocol), 6 an agreement reached in
January 2000 in Montreal and an outgrowth of the Convention on Biological
Diversity (CBD), is one response to these concerns about genetically-modified
organisms (GMOs).7 While there were already some international trade guidelines
for GMOs, the Protocol is the first agreement to require consent by an importing
country before transfer of certain GMOs, for the purpose of assessing risks to
human health and the environment.8 But why is the Protocol only concerned with
the products of genetic engineering, when crop geneticists have a whole array of
methods available to them for use in creating new crop varieties? The Protocol
fixates on a particular process and not on what should be the true focus of a
biosafety agreement: the safety of the resulting product.' 0
This paper examines some of the main structural elements of the Protocol.
Specific attention will be given to how the Protocol's narrow focus of regulating
the trade of GMOs can be counterproductive and potentially quite harmful to the
regions of the globe that stand to benefit the most from the use of GMOs. In part
I, the goal will be to make clear precisely what the Protocol regulates. Part II will
survey the potential benefits and harms associated with GMOs. In part III, the
role of the precautionary principle in the Protocol will be explored, including how
biotechnology fears could circumvent this role. Part IV will look at the "labeling"
requirements of the Protocol and the issues surrounding labeling of GM food in
general. Finally, part V will explore the potential effects of the Protocol and
GMOs on developing nations.
6. Cartagena Protocol on Biosafety to the Convention on Biological Diversity, Jan. 29, 2000, 39 I.L.M. 1027
(2000) [hereinafter Protocol].
7. For a general overview on the Protocol's creation and structure, see Aarti Gupta, Governing Trade in
Genetically Modified Organisms: The Cartagena Protocol on Biosafety, 42 ENV'T. 22, 23 (2000); Pal E Hagm
& John Barlow Weiner, The Cartagena Protocol on Biosafety: New Rules for International Trade in Living
Modified Organisms, 12 GEO. INT'L ENVTL. L. REV. 697 (2000); Gareth W. Schweizer, The Negotiation of the
Cartagena Protocol on Biosafety, 6 ENVTL. L. 577 (2000); Holly Saigo, Agricultural Biotechnology and the
Negotiation of the Biosafety Protocol, 12 GEO. INT'L ENVTL. L. REV. 779 (2000); Helene Cooper & Scott
Kilman, Trade Rules on Biocrops Benign to U.S., WALL ST. J., Jan. 31, 2000, at A3; Andrew Pollack, 130
Nations Agree on Safety Rules for Biotech Food, N.Y. TIMES, Jan. 30, 2000, § I, at 1. Since the United States is
a not a party to the CBD, it cannot be a signatory to the Protocol, though the United States did figure prominently
in the Protocol's shaping. See Gupta, supra at 32.
8. Gupta, supra note 7, at 24; see Hagen & Weiner, supra note 7, at 699, 712.
9. See ALAN MCHUGHEN, PANDORA' S PICNIC BASKET: THE POTENTIAL AND HAZARDS OF GENETICALLY
MODIFIED FOODS 71 (2000).
10. Cf id. (explaining that it is not wise to a make a dichotomy between modem biotechnology and all other
types of breeding techniques if the distinction is based only on safety concerns).
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I. THE STRUCTURE OF THE PROTOCOL AND WHAT THE
PROTOCOL REGULATES
A. Living Modified Organisms (LMOs) Defined
The scope of the Protocol is laid out in article 4: "This Protocol shall apply to
the transboundary movement, transit, handling and use of all living modified
organisms that may have adverse effects on the conservation and sustainable use
of biological diversity, taking also into account risks to human health."" The
Protocol, therefore, regulates living-modified organisms (LMOs), but what are
LMOs? The more common term in the literature is genetically -modified (GM)
organism or GMO, but the Protocol chose to use the term LMO. 12 This paper
will use both terms.
Alan McHughen, a crop geneticist, has pointed out that one of the main
problems of the debate over GMOs is that "[w]e lack a precise, common
definition of a [GM product]."' 3 The Protocol attempts to address that problem
with the term LMO, which it defines in article 3(g) as "any living organism that
possesses a novel combination of genetic material obtained through the use of
modem biotechnology."' 4 This definition has two parts: "living organism" and
"modem biotechnology.'] 5  .' Living organism' means any biological entity
capable of transferring or replicating genetic material, including sterile organisms,
viruses and viroids." t6 A seed, say a kernel of corn, is an example of a living
organism. A plant grown from a seed would also count. "'Modem
biotechnology' means the application of: a. In vitro nucleic acid techniques,
II. Protocol, supra note 6, art. 4, at 1029.
12. The use of LMO over GMO was meant to shift attention away from genetic engineering as the focus of
regulation. Gupta, supra note 7, at 25. The phrase "LMO" apparently serves as a "'boundary ordering device'
around which agreement could cohere, even as differential interpretations of the term continued to persist." AARn
GUPTA, FRAMING "BIOSAFETY" IN AN INTERNATIONAL CONTEXT 5 (Belfer Ctr. for Sci. & Int'l Affairs, ENRP
Discussion Paper E-99-10, 1999), at http://environment.harvard.edu/gea/pubs/e%2D99%2D1 0.pdf
13. MCHUGHEN, supra note 9, at 71. For background on the GM debate, see GENETICALLY MODIFIED
ORGANISMS IN AGRICULTURE: ECONOMICS AND POLITICS (Gerald C. Nelson ed. 2001); Harvest of Fear, at
http://www.pbs.org/wgbh/harvest (This website is an accompaniment to a recent PBS documentary on GM food.).
14. Protocol, supra note 6, art. 3(g), at 1028.
15. For background on the science of genetic engineering, see ALLAN B. COBB, SCIENTIFICALLY ENGIaEEI
FOOD: THE DEBATE OVER WHAT'S ON YOUR PLATE (2000); BREWSTER KNEEN, FARMAGEDDON: FOODANDT E
CULTURE OF BIOTECHNOLOGY 41-49 (1999); id. at 197-206; MCHUGHEN, supra note 9, at 17-60; STEPHEN
NOTTINGHAM, EAT YOUR GENES: HOW GENETICALLY MODIFIED FOOD IS ENTERING OUR DIET 1-26 (1998) For
recent stories on biotechnology and GM crops, see Monsanto's Biotechnology Knowledge Center, at
http://www.biotechknowledge.com.
16. Protocol, supra note 6, art. 3(h), at 1028.
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including recombinant deoxyribonucleic acid (DNA) and direct injection of
nucleic acid into cells or organelles, or b. Fusion of cells beyond the taxonomic
family." 17 Corn that has been so modified would yield a kernel of corn that
would be considered an LMO.
Genes are made of DNA. Genes contain the instructions for making a
protein. Some bacteria known as Bacillus thurigiensis (Bt) have genes that code
for proteins that act as pesticides. These genes have been placed into corn to
yield "Bt-corn.' 18 Bt-corn has caused much concern, because in 2000 a kind of
Bt-corn called "Starlink," which had not been approved for human consumption,
accidentally ended up in some food products. 19 Bt-corn will be used as an
example of a GM crop and an LMO throughout this paper.
B. Protocol's Treatment of LMOs Depends on Their Intended Use
Another problem with the GM debate identified by Alan McHughen is that
"[w]e confuse and coalesce different classes of [GM products] requiring
different kinds and degrees of regulatory scrutiny. ' 20 A complete, living GMO is
different than a processed GM product that contains degraded DNA and a GMO
extract, e.g., vegetable oil that contains neither DNA nor protein.2' The Protocol
does make such distinctions. The Protocol only deals with LMOs, not processed
LMOs.22 As article 3(h) makes clear, a living organism is one that can replic ate
genetic material.2 3 Once an LMO has been processed, it is no longer capable of
replicating genetic information. However, one may still be able to detect genetic
material and the protein products of the genetic material (see part IV C). The
term "GM product" or "GM food" in this note is a general one. "GM product" or
17. Id. art. 3(i), at 1029. The terms biotechnology and genetic engineering will be used interchangeably in this
paper. Recombinant DNA or rDNA technology is also a synonym, as is the term "transgenic."
18. See generally JANET E. CARPENTER, NAT'L CTR. FOR FOOD& AGRIC., CASE STUDIES IN BENEFITS AND
RISKS OF AGRICULTURAL BIOTECHNOLOGY: ROUNDUP READY SOYBEANS AND BT FIELD CORN (2001), aa-dte
at http http://www.ncfap.org/reports/biotech/benefitsandrisks.pdf
19. For background on the Starlink saga, see Henry 1. Miller, No Kernel of Truth, J. FOOD T ECH., Dec. 2000,
at 120, available at http://www.ift.org/products/docshop/ft/index1200.shtml; see also Jill Carroll, Biotech Corn-
Seed Traces Are Detected In Seed Intended for Spring Planting, WALL ST. J., Mar. 2,2001, at B6; Starlink Corn
News Archive, at http://www.epa.gov/pesticides/biopesticides/otherdocs/starlink news.htm. In July 2001, the
Environmental Protection Agency (EPA) had a meeting concerning Starlink, Assessment of Additional Scientific
Information Concerning StarLink Corn, available at http://www.epa.gov/scipoly/sap/200l/july/julyfinal.pdf.
20. McHUGHEN, supra note 9, at 71.
21. Id. at 72.
22. Cooper & Kilman, supra note 7, at A3.
23. Protocol, supra note 6, art. 3(h), at 1028.
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"GM food" may refer to an LMO or to a processed food product that would not
fall under the LMO definition.
1. LMOs Intended for Introduction into the Environment
While the Protocol regulates LMOs, it treats LMOs differently depending on
whether they are destined for introduction into the environment (e.g., seed to be
used for planting crops), or whether they are meant for direct use as food, animal
feed or for processing.24 LMOs in the former group are treated more strictly.
This treatment makes sense because the Protocol arose from the CBD, 25 and
seeds to be planted present the greatest potential danger to the environment.
These LMOs are subject to Advanced Informed Agreement (AIA), which is a
type of prior informed consent. 6 Articles 7 through 10 and 12 discuss the ALA
procedure.27
Article 7 gives a basic overview of the process that a party to the Protocol
must follow when importing, for the first time, a particular LMO "for intentional
introduction into the environment." 28 A mechanism is provided for exempting
certain LMOs from this standard AIA procedure, if the parties agree that they are
safe.29 Article 8 requires an exporting party to notify the country that is to
receive the LMO, including at least the information called for by annex I of the
Protocol .30 Article 9 requires the importer, within ninety days of receiving
notification, to acknowledge the exporting party's notification.3' Article 10
explains the guidelines an importer must follow in deciding whether to accept an
LMO. These guidelines require the potential importer to give its answer not just
to the exporter, but also to the Biosafety Clearing-House (Clearing-House).32
Article 20 outlines the functions of the Clearing-House. 33 Article 10 also allows
for use of precautionary decision-making, 34 which will be discussed in part III of
this paper. Article 12 provides more clarification on the decision procedure
24. See id. arts. 7, 11, at 1030, 1031-32.
25. See Gupta, supra note 7; Schweizer, supra note 7.
26. See Gupta, supra note 7, at 25.
27. Protocol, supra note 6, arts. 7-10, 12, at 1030-33.
28. Id. art. 7, at 1030.
29. See id 4, at 1030.
30. Id. art. 8, 1, at 1030.
31. Id. art. 9, I, at 1030.
32. Id art. 10, 3, at 1031.
33. Id. art. 20, at 1036-37.
34. Id. art. 10, 6, at 1031.
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including reference to risk assessment and risk management, which are described
in articles 15 and 16 respectively.35
2. LMOs Intended for Direct Use as Food, Feed, or for Processing
LMOs marked for direct use as food, feed, or for processing are not subject
to ALA, but other rules do apply and are outlined in article 11.36 These LMOs are
not treated on a transactional basis.37 Rather, when a party decides that it will
allow the importation of a particular LMO for such direct use, it must give notice
within fifteen days by communicating information outlined in annex II to the
Clearing-House. 38 Article 11 also allows for precautionary decision-making and
refers to risk assessment under annex III. 39 Developing countries are allowed to
treat "Article 11 LMOs" under the more strict AIA procedure. 40 There are also
"handling, transport, packaging and identification" rules for these "Article 11
LMOs," outlined in article 1 8. 4 1 These so-called "labeling" requirements are
discussed in part IV.
II. THE PROS AND CONS OF GM CROPS
A. Bt-Corn
As already stated, Bt-com will be used periodically in this note as an example
of a GM crop. Bt is a soil bacterium, which during sporulation produces large
quantities of toxic proteins. When ingested by an insect these toxins attach to the
gut wall and prevent nutrient uptake with fatal consequences.42 There are
different kinds of Bt toxins, some of which are specific for specific kinds of
insects.43 The toxins only kill the larval stage of the insect and are not toxic to
other kinds of organisms.44 Bt toxins have been used commercially as
insecticides since 1958, 45 and Bt sprays were even praised by Rachel Carson as
35. Id. arts. 12, 15, 16, at 1032-34.
36. Id. art. 11, at 1031-32.
37. See Gupta, supra note 7, at 29.
38. See Protocol, supra note 6, art. 11, 1, at 1031-32.
39. See id 6, 9, at 1032.
40. See id. 6, at 1032.
41. Id. art. 18, 2(a), at 1035-36.
42. NOTTINGHAM, supra note 15, at 47; see also Saigo, supra note 7, at 785.
43. See NOTTINGHAM, supra note 15, at 48.
44. Id. at 47.
45. Id
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an alternative to dangerous chemicals like DDT.4 6 A plant (tobacco) was first
modified with a gene encoding for a Bt toxin in 1985. 47 Pesticides, including
those produced by GM crops, are regulated in the U.S. by the Environmental
Protection Agency (EPA).48 Regulation of GMOs in the United States is controlled
mainly by three agencies: the USDA, the FDA, and the EPA. 9
B. Benefits of GM Crops
1. Environmental Benefits
The discussion of GM crops begins with a look at their benefits; an
examination of their downsides will follow. This overview of the positives and
negatives of GM crops will lay the foundation for an examination of the
precautionary principle's role in the GMO debate. The promising future of Bt
corn and GM crops in general appears endless. Insect-resistant crops
demonstrate some of these benefits. Growers will no longer be dependent on
weather conditions when deciding when to spray and will be able to reach parts
of the plant traditionally difficult to reach with sprays.50 Farmers will realize great
46. Id.; see also John Hodgson, GMO Roundup, 19 NAT. BIOTECH. 5 (2001) (pointing out the hypocrisy of
organic food groups for criticizing the use of Bt crops when they themselves use Bt sprays). Butsee 1nN M
supra note 15, at 162 (explaining Bt crops may lead to insect resistance to the toxin, which could hurt the
usefulness of Bt sprays).
47. NOTTINGHAM, supra note 15, at 48.
48. See id. at 126. The EPA's jurisdiction over GMOs derives from the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA) and the Federal Food, Drug and Cosmetics Act (FDCA). Julie Teel, Student Article,
Regulating Genetically Modified Products and Processes: An Overview of Approaches, 8 N.Y.U. ENVTL. L.J.
649, 663 (2000). EPA also has jurisdiction under the Toxic Substances Control Act (TSCA). John Charles
Kunich, Mother Frankenstein, Doctor Nature, and the Environmental Law of Genetic Engineering, 74 S. CALL
REV. 807, 824-831 (2001). One author has argued for the need for more unified legislation. Id. at 859-69. Befor
a pesticide engineered crop destined for food or feed can be field tested, an Experimental Use Permit (EUP) must be
obtained. Teel, supra, at 663 (citing FIFRA). Certain pesticides, including plants expressing pesticides, can be
exempted from the normal regulations if they pose a sufficiently low environmental risk. NOTINGHAM,sarur
15, at 126; see also Teel, supra, at 664. In January 2001, the EPA announced finalized rules, which keep in place
these standards for reviewing GM crops with pesticide expression or "plant-incorporated protectants" (PIPs). Press
Release, Envtl. Prot. Agency, Plant-incorporated Protectant Rules Issued; Comments Invited on Supplemental
Notice and Report (Jan. 17, 2001), http://yosemitel.epa.gov/opa/admpress.nsf. On July 19, 2001, the EPA
solicited additional comments on the exemptions proposed in 1994 for plant-incorporated protectants. Plant-
incorporated Protectants (Formerly Plant-Pesticides), Supplemental Proposal, 66 Fed. Reg. 37855 (July 19, 2001)
(to be codified at 40 C.F.R. pt. 174), available at http://www.epa.gov/fedrgstr/EPA-PEST/200I/July/Day-
19/p I7984.htm.
49. NOTTINGHAM, supra note 15, at 123; MCHUGHEN, supra note 9, at 150. See generallykKfficyIFrar,
Frankenstein Foods or Flavor Savers?: Regulating Agricultural Biotechnology in the United States and European
Union, 7 VA. J. SOC. POL'Y & L. 257, 265-77 (2000); Teel, supra note 48, at 661-67. Foran overview of
agencies' roles and application to Bt corn, see Carpenter, supra note 18.
50. NOTTINGHAM, supra note 15, at 54.
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cost benefits when freed from the many costs involved with spraying.5I A GM
crop is also less expensive to develop than a new chemical insecticide.52
Decreasing or totally eliminating insecticide spraying means more non-target
insects will be protected.5 3 Use of GM crops also does not have to mean
increased production; it can mean maintenance of current production levels while
using fewer acres. 5 4 More efficient use of the land means more space for nature,
and consequentially a boost for biodiversity 5 5 GM crops should result in better
soil conservation.5 6 Phytoremediation or the cleansing of contaminated soil using
plants should be made easier. 57 Groundwater contamination should also be less
of a problem with these crops.5 8 Furthermore, new crop varieties may be
designed to use water more efficiently. 9
2. Health Benefits of GM Crops
The positive effects of GM crops are not limited to the environment.
Decreasing or eliminating the need to spray should mean less danger for spray
operators, especially in developing countries.60 People who consume GM crops
will not have to worry as much about chemical residues. Crops that are more
nutritious will be available, including rice with Vitamin A to help prevent
51. Id.
52. Id.
53. Id. at 54-55.
54. McHuGHEN, supra note 9, at 107; see also Borlaug, supra note 5, at A22; INDUR M. GoKLANY,CIRFR
THE STUDY OF AM. BuS, APPLYING THE PRECAUTIONARY PRINCIPLE TO GENETICALLY MODIFIEDCRM PICY
STUDY NO. 157, (2000), available at http:/lcsab.wustl.edu/csab/CSAB%20pubs-
pdfl 20files/Policy%2OStudies/ps I 57%20goklany-gm%20foods2.pdf; Jonathan H. Adler, The Cartagena Protocol
and Biological Diversity: Biosafe or Bio-sorry?, 12 GEO. INT'L ENVTL. L. REV. 761, 772 (2000); NA'L ACAD.
OF SC., supra note 1, at 10.
55. L. L. Wolfenbarger & P. R. Phifer, The Ecological Risks and Benefits of Genetically Engineered Plants,
290 SCIENCE 2088, 2091 (2000).
56. See id; see also GOKLANY, supra note 54, at 10; NAT'L. ACAD. OF SCI., supra note 1, at 11. But see
NOTTINGHAM, supra note 15, at 163 (explaining that transgenic crops that do well in poor soils can breed
complacency that in turn can lead to further environmental degradation); MICHAEL W. Fox, SUPERPIGS AND
WONDERCORN 62 (1992) (arguing that because salinization and drought are primarily man-made, it would make
more sense to take care of these problems directly, instead of using genetic engineering as a crutch). A salt resistant
tomato has recently been developed. See Hong-Xia Zhang & Eduardo Blumwald, Transgenic Salt-Tolerant
Tomato Plants Accumulate Salt in Foliage but Not in Fruit, 19 NAT. BIOTECH. 765 (2001).
57. See Wolfenbarger & Phifer, supra note 55, at 2091-92; see also GOKLANY, supra note 54, at 12.
58. NOTTINGHAM, supra note IS, at 54.
59. Sandra Postel, Growing More Food With Less Water, SC. AM., Feb. 2001, at 46, 50.
60. See NOTTINGHAM, supra note 15, at 55.
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blindness. 6' There will even be plant varieties containing vaccines. 62 More will
be said of these health benefits in the context of developing countries in part V.
C. Safety Concerns about GM Crops
1. Environmental Concerns about GM Crops
The use of GM crops involves many uncertainties and Bt crops are no
exception. Bt toxins are proteins and as such are biodegradable.63 However,
there remains much uncertainty about the extent of bioaccumulation for Bt toxins.
Bioaccumulation is a concern because it could help promote insect resistance to
Bt toxins in insects.64 Such resistance has already been observed in both the field
and in the laboratory. However, development of such resistance may be slowed
or eliminated by planting refuges of non-GM crops in GM crop fields.
65
A major environmental concern with GM crops is the uncertainty whether a
GM crop could become a weed either by itself or by transferring its modified
genes to wild relatives.66 Adding to this uncertainty is the large number of
different ecosystems that a crop variety might end up in, and what effect it would
have in each.67 Unplanned spread of GM crops and their genes in the
environment will probably occur more through seed spillage than through pollen
61. Press Release, Int'l Rice Research Inst., The Rockefeller Found. & Syngenta AG, "Golden Rice" Arrives in
Asia (Jan. 19, 2001), available at http://www.irri.org/vis/line200l.htm; see also T. A. Heppenheimer, 177DNA
Dilemma, AM. HERITAGE INVENTION & TECH., Spring 2001, at 8, 16 (relating that vitamin A deficiency also kills
over a million children a year).
62. See NAT'L. ACAD. OF S Cf., supra note 1, at 12-13; see generally Langridge, supra note I.
63. SeeNoTINGHAM, supra note 15, at 55.
64. See Wolfenbarger & Phifer, supra note 55, at 2089.
65. See MCHUGHEN, supra note 9, at 108; GOKLANY, supra note 55, at 17; Douglas A. Powell et al., A
Survey of Ontario Corn Producers to Assess Compliance with Refugia Recommendations to Manage Development
of Resistance to Genetically Engineered Bt-Corn in the European Corn Borer, 1999 Technical Report No. 009,
July 21, 1999, available at http://www.plant.uoguelph.ca/safefood; Wolfenbarger & Phifer, supra noe 55, at 2092.
66. GOKLANY, supra note 54, at 18-19; NOTTINGHAM, supra note 15, at 80; Saigo, supra note 7, at 787-00,
Teel, supra note 48, at 656; see also Wolfenbarger & Phifer, supra note 55, at 2088. But see Cliff D. Weston,
Chilling of the Corn: Agricultural Biotechnology in the Face of US. Patent Law and the Cartagena Protocol, 4
J. SMALL & EMERGING Bus. L. 377, 403 (2000) (stating that it is unlikely that weeds that live amongst GM crops
will inherit tolerance from such crops); Borlaug, supra note 5, at A22 (pointing out that resistance genes added to
crops using conventional methods can also be spread to wild relatives, and adding that steps can be taken to hlp
prevent transfer). A 10-year study conducted by the Imperial College in London showed that transgenic plants were
no more likely to spread than their natural counterparts, with neither traditional nor modified plants increasing to
numbers greater than their original plantings. Mwingirwa Kithure, GM Crops Safe, THE NATION (NARc, May
24, 2001, available at http://allafrica.com/stories/200l05230524.html.
67. See MCHUGHEN, supra note 9, at 161-63; see also Schweizer, supra note 7, at 584.
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transfer to wild relatives.68 Seed spillage is particularly likely to occur in
developing countries.69
2. Health Concerns about GM Crops
a. Allergies
Complaints about the potential negative effects of GM products on health
tend to be grouped into two categories: allergies aid antibiotic resistance.
70
About one to two percent of populations in Western countries have some type of
food allergy.7 1  The transfer of genes to a food product may change the
allergenicity of that food.72
One example of a food allergen introduced into a food that was ordinarily not
allergenic involves soybeans and a protein from the Brazil nut.73 Soybeans, as a
68. MCHUGHEN, supra note 9, at 166 (making this point and continuing on to explain that one regulator
official in Great Britain would insist on keeping track of every seed!).
69. Schweizer, supra note 7, at 593 n. 112.
70. See Francer, supra note 49, at 251-55; John Sephen Fredland, Unlabel Their Frankenstein Foods:
Evaluating a US. Challenge to the European Commission's Labeling Requirements for Food Products
Containing Genetically-Modified Organisms, 33 VAND. J. TRANSNAT'L L. 183, 188 (2000).
71. NOTTINGHAM, supra note 15, at 91. For a general overview of biotechnology and allergy risks, see
generally ROYAL SOC' Y OF CAN., ELEMENTS OF PRECAUTION: RECOMMENDATIONS FOR THE REGULATION OF
FOOD BIOTECHNOLOGY IN CANADA 53-75 (2001), available at
http://www.rsc.ca/foodbiotechnology/GMreportEN.pdf This report is still of value for reference, however, the
Canadian government has since distanced itself from its main finding. Peter Calamai, Ottawa Changes Mind on
GM Food Report Findings, TORONTO STAR, Aug. 23, 2001, at A16, available at 2001 WL 25815658 ("Health
Canada officials had denounced the report's key finding, which said the main concept underlying federal rules on
modified products was 'scientifically unjustifiable."'). Another report on the regulation of GM foods inCaldawas
released in August 2001. CANADIAN BIOTECHNOLOGY ADVISORY COMMITTEE, IMPROVING THER.EGut-An'NOF
GENETICALLY MODIFIED FOODS AND OTHER NOVEL FOODS IN CANADA: INTERIM REPORT TO THE CYVERNM
OF CANADA BIOTECHNOLOGY MINISTERIAL COORDINATING COMMITTEE (Aug. 2001),
http://www.plant.uoguelph.ca/safefood/gmo/cbac.pdf. For a criticism of this apparent about-face, see Ann Clark,
Contradictory Reports Baffle Public, TORONTO STAR, Aug. 22, 2001, at A22, available at 2001 WL 25816877.
For more on GM cops and allergies, see Bob B. Buchanan, Genetic Engineering and the Allergy Issue, 126
PLANT PHYSIOLOGY, May 2001, at 5, available at http://www.plantphysiol.org/cgi/content/full/l26/l/5; Michael
Fumento, Anti-Allergy Biotech, AMERICAN OUTLOOK, May/June 200 1, available at htlp'/fumernto.com/fixJcftnl
(providing an interview with an industry regulatory science specialist about allergens in transgenic foods).
72. NOTTINGHAM, supra note 15, at 92 (noting only trace amounts transferred, but trace amounts are often
enough to cause allergy problems). But see Andrew Pollack, Plan for Use of Bioengineered Corn in Food is
Disputed, N.Y. TIMES, Nov. 29, 2000, at C4 (explaining in reference to Cry9C protein of Starlink corn, that there
is so little of the protein in the corn to begin with, that after processing there unlikely to be enough to cause allergy
problems). A recent report produced by Aventis for the EPA shows that the method of processing determines how
much of the protein remains. Wet -milling resulted in protein levels below the level of detection and dry-milling
the protein is denatured but not completely eliminated. New StarlinkTM Corn Data Submitted by Aventis
CropSciences, available at http://www.epa.gov/pesticides/biopesticides/otherdocs/stlink/stlinkdata.html (Apr. 23,
2001).
73. MCHUGHEN, supra note 9, at 119-21.
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member of the legume family, are low in the amino acid methionine and cysteine,
two of the building blocks of proteins.74 People whose diets are almost
exclusively bean-based face a nutritional deficiency. 75 Brazil nuts contain a
protein that is rich in these particular amino acids, so researchers saw transferring
the gene coding for this protein as a way of solving a nutritional problem.
76
Unfortunately, the protein also turned out to be an allergen.77 The bean was never
produced commercially, and researchers realized the problem of transferring such
a protein before any of the beans were made. 78  Allergenicity is certainly a
concern for GMOs and the foods derived from them, but it is a relevant concern
for all novel foods, regardless of whether they were modified using
biotechnology. One must also appreciate that biotechnology gives us the potential
to eliminate known allergens from foods.79
The Starlink or Cry9C corn, 80 the Bt corn that accidentally entered the food
supply, 8' also illustrates the issue of allergenicity. The Cry9C Bt protein is stable
in stomach acid, meaning it could conceivably be an allergen. 82 However, there
are such low levels of tie Bt protein in GM corn to begin with that, after
processing, it is doubtful that there would be a problem even if the protein did
turn out to be allergic to some people. 83 To put things in perspective, plants have
evolved a vast array of natural toxins. With Americans, by one count, consuming
up to ten thousand such natural pesticides and on average 1500 mg daily, genetic
74. Id. at 120.
75. Id at 119-20.
76. Id at 120.
77. Id.
78. 1d; see also NOTTINGHAM, supra note 15, at 92 (stating that allergenicity of protein shown in people who
knew they were allergic to Brazil nuts). Testing was performed though not required. KRISTIN DAWKINS, GENE
WARS: THE POLITICS OF BIOTECHNOLOGY 33-34 (1997). But see Sarah Lueck, U.S. Notification Required to
Market Gene-Altered Food, WALL ST. J., Jan. 18, 2001, at B12 (stating new FDA rules indicate that such testing
will now be required). For a Canadian perspective of GM foods and alergenicity, see Angela Altass, Relax: GM
Foods Won't Trigger an Allergy Epidemic available at http://www.agcanada.com/cg/gmfoods.htm.
79. See MCHUGHEN, supra note 9, at 161.
80. For details on the Cry9C protein, see http://www.starlinkcom.com.
81. See Barnaby J. Feder, Farmers Cite Scarce Data In Corn Mixing, N.Y. TIMES, Oct. 17, 2000, at C1.
82. Pollack, supra note 72.
83. Id; see also Steve Milloy, Get the Butterfly Net for Inattentive Media, at
http://www.cato.org/dailys/12-09-O0.html (Dec. 9, 2000) (explaining that the protein is not a significant allergenic
risk); Jill Carroll, No Evidence Found of StarLink Causing Allergic Reactions, WALL ST. J., June 14, 2001, at
B4. Other Bt crop varieties expressing different Bt toxins are rapidly digested and regarded as safe. See Ka= A
Goldman, Labeling of Genetically Modified Foods: Legal and Scientific Issues, 12 GEO. INT'L ENVTL. L. REV.
717, 748 (2000). A recent study by the Centers for Disease Control failed to find any allergic reaction between the
Starlink Cry9C protein and human samples. Investigation of Human Health Effects Associated with Potential
Exposure to Genetically Modified Corn: A Report to the US. Food and Drug Administration from the Centers
for Disease Control and Prevention, available at http://www.cdc.gov/nceh/ehhe/Cry9cReport/cry9creport.pdf.
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modification through modem biotechnology does not appreciably change these
levels.8 4
b. Antibiotic Resistance
Many GM crops contain an antibiotic -resistance gene in addition to the gene
for the protein that a plant breeder wants to transfer. The antibiotic gene allows
the scientist to select which plants actually receive the gene of interest. The same
antibiotics used in this process are also used for medical purposes. Some studies
have claimed a health risk because of a concern that bacteria living in our gut
could pick up these antibiotic resistance genes, thus reducing the effectiveness of
these antibiotics.8 5 However, the risk of such a gene transfer in nature is
exceedingly low. 8 6 Over-prescription of unnecessary antibiotics and patient non-
completion of prescribed antibiotic regimes are much more effective targets for
regulators concerned with slowing the development of resistant bacterial swains. 87
In addition, scientists can now remove antibiotic marker genes from crops
before they are commercially developed.
88
III. THE PRECAUTIONARY PRINCIPLE AND ITS IMPLICATIONS FOR
GM CROPS
A. An Introduction to Uncertainty and the Precautionary Principle
The complexity of ecosystems and the human body make predictions difficult
and uncertain: "Ecosystems are complex, and not every risk associated with the
release of new organisms, including transgenics, can be identified, much less
considered. Unknown risks may surface as the frequency and scale of the
introduction increases. 89 Uncertainties regarding novel plant breeding techniques
84. J. Howard Beales II, Modification and Consumer Information: Modern Biotechnology and the Regulation
of Information, 55 FOOD DRUG L.J. 105, 106 (2000); see also MCHUGHEN, supra note 9, at 167 (explaining that
if we used the same modem technology and standards that we apply to gin foods that we do to conventional foods,
the presence of toxins would call such foods as coffee, fruits with stones, chocolate, potatoes, etc. into question).
85. NOTTINGHAM, supra note 15, at 93-94; see id. at 95. In the context of GM food labeling, see Goldman
supra note 83, at 736-39.
86. McHUGHEN, supra note 9, 185-86.
87. Id. at 186.
88. NAT'L. ACAD. OF SCI., supra note I, at 16.
89. Wolfenbarger & Phifer, supra note 55, at 2090; see also C. Neal Stewart, Jr. & Sarah K. Wheaton, GM
Crop Data-agronomy and Ecology in Tandem, 19 NAT. BIOTECH. 3, 3 (2001) ("[B]iosafety data could be gathered
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are nothing new. In 1906, in reference to what we now term "conventional
techniques," Luther Burbank noted, "we recently advanced our knowledge of
genetics to a point where we can manipulate life in a way never intended by
nature. We must proceed with utmost caution in the application of newfound
knowledge." 90 Today, people have similar concerns regarding plants and other
organism engineered using modem biotechnology.
The Protocol answers theses concerns by incorporating the precautionary
principle, 9' which is found in articles 10 and 11.92 There is no universally agreed-
upon definition of the principle. 93 Nevertheless, the Protocol defines the principle
in regards to LMOs to be introduced directly into the environment as follows:
Lack of scientific certainty due to insufficient relevant scientific
information and knowledge regarding the extent of the potential
adverse effects of a living modified organism on the
conservation and sustainable use of biological diversity in the
Party of import, taking also into account risks to human health,
shall not prevent that Party from taking a decision, as
appropriate, with regard to the import of the living modified
efficiently if US researchers would collect ecological data during large-scale trials and commercial uses of GM
crops.").
90. Beales, supra note 84, at 110. See generally Heppenheimer, supra note 61, at 8-16 (discussing the early
days of genetic engineering and the debate over its health and safety within the scientific community, as well as on
a local, state, and national level).
91. See Andrew Pollack, Talks on Biotech Food Turn on a Safety Principle, N.Y. TIMES, Jan. 28, 2000, at A4.
For a general elemental approach to the precautionary principle, see generally John S. Applegate, The
Precautionary Preference: An American Perspective on the Precautionary Principle, 6 HUM. & EcrUCaCALRISK
ASSESSMENT 413 (2000). For a general application of the principle to GMOs, see generally ROYAL SOC'Y OF
CAN., supra note 71, at 192-210. In July 2001, the United Nations Development Programme issued its 2001
report on human development, which looks at the issues of risk concerning biotechnology and GM crops, including
a discussion of the precautionary principle. UNITED NATIONS DEVELOPMENT PROGRAMME, Mamging the Ris of
Technological Change. HUM. DEV. REP. 2001, ch.3, (July 2001), available at http://www.undp.org/hdr200l.
92. Protocol, supra note 6, arts. 10 & I1, at 1031-32.
93. David Appel, The New Uncertainty Principle, SO. AM., Jan. 2001, at 18, 18.
Although there is no consensus definition of what is termed the precautionary principle,
one ofi -mentioned statement, from the so-called Wingspread conference in Racine, Wis., in
1998 sums it up: "When an activity raises threats of harm to human health or the
environment, precautionary measures should be taken even if some cause and effect
relationships are not fully established scientifically."
Id.
For various definitions of the precautionary principle, see KNEEN, supra note 15, at 140 ("The
precautionary principle, as defined by the 1990 Bergen Ministerial Declaration, says 'Where there are threats of
serious or irreversible damage, lack of full scientific certainty should not be used as a reason for postponing
measures to prevent environmental degradation.' In other words, err on the side of caution."). See also
MCHUGHEN, supra note 9, at 139.
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organism in question .... in order to avoid or minimize such
potential adverse effects.94
In the context of the Protocol, the "trigger" 95 for the precautionary principle
is the proposed importation of an LMO. An importing country has the choice of
either allowing an LMO in or holding off until such time that it has enough
scientific data so as to be more certain that importation would be safe. Having
the default position at no importation gives a country a great deal of flexibility,
whether this is too much flexibility is a matter of debate.
B. Possible Conflicts of the Protocol with the WTO
Differences in precautionary approaches amongst treaties, especially the
differences between the Protocol's approach and that taken by the WTO's
Agreement on the Application of Sanitary and Phytosanitary Measures (SPS), 96
may be grounds for future trade wars. 97 While the Protocol probably will not
take precedence over the WTO, 9 8 conflicting statements in the Protocol's
preamble and ambiguous language elsewhere create significant confusion
regarding priority issues. 99 For example, the preamble reads: "Emphasizing that
this Protocol shall not be interpreted as implying a change in the rights and
obligations of a Party under any existing international agreements,",00 which is
immediately followed by "Understanding that the above recital is not intended to
subordinate this Protocol to other international agreements."''0
Notwithstanding the above concerns, the precautionary approaches of the
Protocol and the WTO are not very different. The SPS requires that countries
94. Protocol, supra note 6, art. 10, at 1031; see also id art. 11, at 1031-32 (giving a similar definition for
"article 11 LMOs").
95. See Applegate, supra note 91, at 416.
96. See Agreement on the Application of Sanitary and Phytosanitary Measures, Apr. 15, 1994, Marrakesh
Agreemmt Establishing the World Trade Organization [hereinafter WTO Agreement], Annex IA, 69 (1994)
[hereinafter SPS Agreement], available at http://www.wto.org/english/docs-e/legal-e/15-sps.pdf.
97. SeeDAWKINS, supra note 78, at 35-39; see also NOTTINGHAM, supra note 15, at 136 ("The USA is likely
to use its powers under the WTO if it feels any of its transgenic crops exports are being unfairly treated in
Europe."); Gupta, supra note 7, at 31. For similar reasoning in regards to potential trade wars over label igofGM
foods, see Lara Beth Winn, Special Labeling Requirements for Genetically Engineered Food: How Sound Are the
Analytical Frameworks Used by FDA and Food Producers?, 54 FOOD DRUG L.J. 667, 687 (1999). See also
Fredland, supra note 70.
98. See Teel, supra note 48, at 701.
99. See Gupta, supra note 7, at 30-31; see also Hagen & Weiner, supra note 7, at 706-08.
100. Protocol, supra note 6, pmbl., at 1027.
101. Id
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use sound science in designing their regulations pertaining to human, animal, and
plant health and safety. 102 Precautionary decision-making is permitted, but only
temporarily until more scientific evidence is gathered.'0 3 Under article 15, the
Protocol also calls for "sound science" as part of a risk assessment procedure laid
out in annex J11.104
C. A Pessimistic Protocol?
The chief failure of the Protocol's use of the precautionary principle and risk
assessment of LMOs may be its fixation on potential harms, while ignoring
potential benefits. 0 5  Indur Goklany has explained that this kind of selective
application of the precautionary principle has already been used to justify a ban of
GM crops.' 0 6  He believes that this misapplication happens because the
precautionary principle alone does not provide any guidance on how it should be
applied in areas where regulatory decisions could result in both "uncertain benefits
and uncertain costs to public health and the environment."' 1 7 His application of
the precautionary principle to GM crops shows that a ban on GM crops "would
increase overall risks to public health and to the environment. Thus it would be
more prudent to research, develop, and commercialize [GM crops] than to ban
such crops, provided reasonable caution is exercised."' 08
A recent report issued by the Royal Society of Canada suggests that the
Protocol's version of the principle is relatively lenient:
The most permissive (minimally precautionary) interpretations
of the principle, on the other hand, place most of the burden of
proof upon those who allege potential risks, while perhaps
relaxing the standards of proof (this is the only "precautionary"
102. See SPS Agreement, supra note 96; Gupta, supra note 7, at 25.
103. See SPS Agreement, supra note 96; Gupta, supra note 7, at 25.
104. Protocol, supra note 6, annex III, at 1045-46.
105. See Henry I. Miller & Gregory Conko, The Protocol's Illusionary Principle, 18 NAT. BIOTECi. 360,360
(2000) [hereinafter Miller & Conko, Protocol's Illusionary Principle]; cf Heppenheimer, supra note 61, at 8 ("As
in so many areas of life, relative costs and benefits always need to be balanced in deciding how to regulate a new
technology. A classic example of this give-and-take occurred in the 1970s, as molecular biologists" were
developing the fundamentals of biotechnology.). For a general criticism of the precautionary principle and its role
in the Protocol, see Henry 1. Miller & Gregory Conko, The Sience of Biotechnology Meets the Politics of Global
Regulation, IssuEs SO. & TECH., Fall 2000, at 47, 48 [hereinafter Miller & Conko, Science of Biotechnologyl
106. GOKLANY, supra note 54, at I.
107. Id.; see also ROYAL SOC'Y OF CAN., supra note 71, at 196 (arguing precautionary principle could lead to
over regulation that could prevent realization of GMO benefits).
108. GOKLANY, supra note 54, at 2; see NAT'L. ACAD. OF SC., supra note 1, at 19.
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aspect), but they insist that the social and economic costs of
exercising restraint be balanced against the potential risks. They
"open the door to cost-benefit analysis and discretionary
judgement." The formulations of the Precautionary Principle in
the Rio Declaration and the Cartagena Biosafety Protocol are
both examples of this kind of cost-effectiveness approach. 0 9
The basis for this classification of the Protocol's version of the principle is not
immediately obvious. Beyond the use of"sound science," the Protocol does not
appear to put many limitations on importers in deciding whether to allow the
import of an LMO.
GM crops do have the potential to harm biodiversity via "genetic erosion."
10
Genetic erosion is defined as a decrease in biodiversity. Biotechnology, together
with modem agricultural practices, has the potential to increase the rate of genetic
erosion.' 1 The introduction of exotic species is another major threat to
biodiveristy, especially endangered species. 12  Kudzu is one of the more
infamous exotic plant species that became a serious weed, 1 3 and it is not a GMO.
The Protocol made a serious error when it singled out GMOs as possible weeds,
since there is little basis to assume that GMOs pose any unique threat to an
ecosystem.1 4 Jonathan Adler has remarked: "The sad irony of the Biosafety
Protocol is that it may well retard, rather than advance, the protection of
biodiversity. Under the guise of adopting 'precautionary' measures to protect the
environment, the Protocol could restrict one of the most important tools for
biodiversity conservation-agricultural biotechnology."'"l 5 As has already been
discussed, GM crops can mean increased productivity with less clearing of
109. ROYAL SOC'YOF CAN., supra note 71, at 197 (citation omitted).
110. Saigo, supra note 7, at 793-96.
II1. Id. at 793.
112. Adler, supra note 54, at 767.
113. See generally EDWARD TENNER, WHY THINGS BITE BACK: TECHNOLOGY AND THE REVENGE OF
UNINTENDED CONSEQUENCES 145-47 (1996).
114. See Adler, supra note 54, at 774; see also Carol Kaesuk Yoon, Some Biotech Upstarts Fizzle Against
Native Plants, N.Y. TIMES, Feb. 20, 2001, at F2 ("Just being genetically engineered does not make a plant any
more likely to become an invasive or persistent weed, according to a huge new decade-long study published this
month in Nature.").
115. Adler, supra note 54, at 763-64. But see MICHAEL W. FOX, BEYOND EVOLUTION 56 (1999) ("tC1'iad
reasonable to conclude that biotechnology is being applied as a band-aid remedy for the diseases and other
production-related problems of both crops and factory-farmed animals whose environments are stressful and disease
inducing.").
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habitat." 1 6 The drafters of the Protocol may have had good intentions. However,
good intentions do not necessarily lead to good law." 17 Furthermore, efforts to
stop a particular danger, as history has demonstrated, can end up having the
opposite effect." 18
D. The Fear Factor: When Emotions Cloud the Facts
The precautionary principle's position that a GMO should be excluded from
commerce until a country believes that there is sufficient certainty that it will not
harm people or the environment is a valid approach. However, the precautionary
principle can be abused. People can fear the process of genetic engineering and
use the principle as a shield or as an excuse. "19 For example, a country could
refuse to allow the import of a GM crop because it just does not like the process
of genetic engineering. This country claims that they are refusing the GMO
because of valid concerns.120 In reality, they are being disingenuous.
A country may make an honest decision based on the existing scientific
information. The problem is that, because of the power of public opinion, a
country may cave into fear and make it a practice not to allow any GMOs. This
problem is demonstrated in part by the sentiment surrounding the EU's recent
(February 2001) passage of new rules regulating GMOs and movement toward
lifting a moratorium on approval of GM crops.' 21 The strict nature of the new
rules is a response to the fear Europeans have of GM foods. 1 22 It also reflects a
desire on the part of some EU members for even stricter rules:123 "Even if a
product is approved at the EU level, countries such as Austria and France might
refuse to allow the use of genetically modified products on their territory.'' 124
116. See Adler, supra note 54, at 773-74; see discussion infra Part I.B I.
117. Cf. John R. Lott, Jr., Gun Laws Can Be Deadly Too, WALL ST. J., May 15, 1999, at A22 ("Good
intentions don't necessarily make good laws.").
118. See TENNER, supra note 113, at 72; Lott, supra note 117, at A22 ("Regulations have both costs and
benefits, and rules that are passed to solve a problem can sometimes make it worse.").
119. See Miller & Conko, Protocol's Illusionary Principle supra note 105, at 360.
120. Cf. Fredland, supra note 70, at 205 (A country would conceivably need only find a single scientist to issue
a report claiming an environmental or health risk to stop the import of an LMO.); Adler, supra note 54, at 768-69
("This language from Article 8(g) is sufficiently broad and tentative to justify almost any level of GMO regulation
by individual countries.").
121. See Donald G. McNeil, Jr., Europe Approves Strict Food Rules, N.Y. TIMEs, Feb. 15, 2001,atAl;Geoff
Winestock, EU Strengthens Rules for Crops with New Genes, WALL ST. J., Feb. 15, 2001, at A 14.
122. McNeil, supra note 121, at Al.
123. See Winestock, supra note 121.
124. Id.
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Uncertainty or rational concerns about the safety of GM foods, and fear of
everything genetically-modified are not the same thing. Fear arises not from
uncertainty but from misunderstanding. 125  However, people can understand
something and still decide they do not like it. The right-to-know argument says
that people have a right to know whether their food has been genetically
modified.126 While right-to-know seems on the surface to be a reasonable enough
position, it turns out to be wrought with difficulties. These labeling difficulties
will be explored in depth in Part IV. For now, it is important to point out some of
the connections between fear and labeling. Consumer fear has been given as the
chief reason why consumers want labeling of GM foods. 27 Additionally, labeling
requirements for GM foods in the EU seem to have been passed because of fear
amongst consumers. 128 Consumer fear together with the labeling requirement of
the Protocol will also likely encourage the failure of GMOs in the marketplace. 1
29
1. Regional Differences in Sentiments Toward GM Food
The contrast in sentiment between the U.S. and Europe is remarkable. ' 30 The
bovine spongiform encephalopathy (BSE) or mad cow disease crisis that has
gripped Europe, and particularly the UK, is probably one of the factors
responsible for this difference.' 3' Some activists have even suggested, quite
125. See Ambuj Sagar et al., The Tragedy of the Commoners: Biotechnology and Its Publics, 18 NAT.
BIOTECH. 2, 3 (2000) (asserting that this linkage of fear and misunderstanding is likely related to the issue of risk
perception). See generally Paul A. Slovic, Perception of Risk, 236 SCIENCE 280 (1987) (offering backgroundon
the topic of risk perception); Clayton P. Gillette & James E. Krier, Risk, Courts and Agencies, 138 U.PA.L REV.
1027 (1990) (discussing selective aversion to new technologies); Richard Pildes & Cass R. Sunstein, R
the Regulatory Stat 62 U. CHI. L. REV. 1, 29-33 (1995) (looking at public's perception of risk in the context of
the regulatory state). However, this idea of fear and misunderstanding is a distinct concept. With fear there is an
absolute or general dislike of a particular technology or item. With risk perception there is primarily just a
misunderstanding of the relative danger of a technology or item, there is not necessarily a dislike of the same.
126. See NOTTINGHAM, supra note 15, at 14748; see also discussion infra Part IV.D.
127. See Winn, supra note 97, at 677-78.
128. Fredland, supra note 70, at 212.
129. Weston, supra note 66, at 406.
130. See McHughen, note 9, at I, 105; Francer, supra note 49, at 294-300; Fredland, supra noe 70, al 189, sw
also Patrice Laget & Mark Cantley, European Responses to Biotechnology: Research, Regulation, and Dialogue,
ISSUES IN SC. & TECH., Summer 2001, at 37, 40 ("Although differences in opinion between EC and U.S. experts
were not great, public attitudes in Europe took a separate path."); Philipp Aemi, Public Attitudes Towards
Agricultural Biotechnology in Developing Countries: A Comparison between Mexico and the Philippines, at
http://www2.cid.harvard.edu/cidbiotech/dp/discussion-aemi.pdf (offering a look at opinions about biotechnology in
developing countries).
131. See Sagar et al., supra note 125, at 2; Fredland, supra note 70, at 188; see also Julia A. Moore, Mare 7ha
a Food Fight, ISSUES IN Sci. & T ECH., Summer 200 1, at 31, 32-33.
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erroneously, that BSE was caused by genetic engineering.' 32 Another factor has
been a recent problem with doxin-tainted food.' 33 Another theory for the
differences in public sentiment is that the regulatory process is much more open
in the U.S. than Europe, where decision-making is often elite and closed-door.'
34
Nevertheless, anti-biotech sentiment may be rising even in the U.S.
135
2. Myths and Poor Reporting
Myths and the urban legends of biotechnology are additional culprits of GM
food fears.' 36  Poor journalism is partly responsible for the spread of these
myths. 137 "Journalists have always been shameless purveyors of the well-told
anecdote as a means of conveying a large trend or idea.' 38  That type of
statement is an over-generalization, and is not a fair characterization of most
journalists. 139  However, there have been some significant weaknesses in
reporting on biotechnology.' 40  These weaknesses are partly due to those
journalists who do not have a good grasp of the underlying science. ' 4' There is
also a general tendency to emphasize bad news over good news. Whereas the
media gave unbelievable amounts of attention to stories suggesting that the Bt
Cry9C protein, found in Starlink corn, might be an allergen and that Bt might be a
serious risk to butterflies, they paid relatively little attention when researchers later
announced that these risks were insignificant.'
42
The Monarch Butterfly/Bt-corn controversy is an excellent example of how
issues can get confused by the media and the public. 143 Butterflies belong to the
same biological grouping as the corn pests that plant geneticists were targeting.
144
So while the harm to butterflies caused by pollen from Bt corn may have been
132. McHUGHEN, supra note 9, at 175. But see id. at 175 ("Both BSE ('mad cow disease') and GMOs seem
to result from or in the intensification of agriculture. Industry drives the fastest, most efficient possible route to
generate food, for example, feeding cattle with whatever is readily available or cheap.").
133. Sagar et al., supra note 125, at 2; see also Francer, supra note 49, at 311.
134. Sagar, et al. supra note 125, at 2; see also Francer, supra note 49, at 311.
135. See Francer, supra note 49, at 298.
136. See generally MCHUGHEN, supra note 9, at 114-21 (explaining the truth behind a number of infamous
stories about GM products).
137. See id. at 177-78.
138. Stephen S. Hall, Fabulous Science, TECH. REV., Nov./Dec. 2000, at 115.
139. For example, many good news sources have been cited in this note.
140. See Francer, supra note 49, at 307.
141. See McHUGHEN, supra note 9, at 177.
142. Milloy, supra note 83.
143. See MCHUGHEN, supra note 9, at 178.
144. Id.
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unintended, it was not unexpected. 145 In addition, the Bt toxin is toxic whether it
is expressed by a plant or is sprayed by an organic farmer. 146 Subsequent
research has shown that the risk of Bt corn to Monarchs to be far less than
originally believed.' 47 A more serious threat to Monarchs appears to be the
destruction of their wintering grounds in Mexico. 148 Additionally, new varieties
will be developed that do not express the Bt toxin in their pollen. 149
Sometimes the underlying science is flawed, and that can help breed fear and
confusion. The findings of Arpad Pusztai, a researcher in Scotland, have caused
some of the greatest controversy regarding the health effects of GM crops.150
Dr. Pusztai fed GM potatoes containing an insecticide gene (from snowdrops) to
rats and claimed it poisoned them.' 51 Despite Pusztai' s claims that the public was
being treated as human guinea pigs, the potatoes were never meant for human
consumption. 152  Additionally, the Royal Society criticized the rat studies as
'"flawed in design, execution and analysis,' and lack[ing] detailed controls.' 153
Nevertheless, even if such studies show that GMOs do not pose health problems,
some scientists are concerned that there is no proof of their long-term
consequences.' 
54
3. Anti-Biotechnology Activism
Some anti-biotechnology activists are also adding to public confusion about
GM goods. Jeremy Rifkin, one of the more prominent activists, has a long
history as a militant foe of technology-organizing protests, writing books, and
145. Id. at 189.
146. Id. at 190.
147. Mark Henderson, Threat That Never Was, TIMES OF LONDON, Dec. 14, 2000,
http://www.thetimes.co.uk/article/O,,74-50894.00.html; Milloy, supra note 83; see also Dick Ahistrom,
Butterflies Fox Scientists Out in the Field of Corn, THE IRISH TIMES ON THE WEB, May 24, 2001, at
http://scripts.ireland.com/search/highlight.plx?TextRcs=&Path=/newspaper/science/2001 0524/sci4.htm
(describing a Canadian study that showed minimal effects of the toxin on butterflies); Gene-altered Corn Seen as
Slight Risk, SAN DIEGO UNION & TRIBUNE, July 25, 2001, at A9, available at 2001 WL 6474553 ("Though
there is a small chance that one in 100,000 monarch caterpillars could be affected by toxic com pollen, research
suggests even those larvae will mature into healthy butterflies, the agency reported.").
148. See GOKLANY, supra note 54, at 17; ROYAL SOC'Y OF CAN., supra note 71, at 210.
149. MCHUGHEN, supra note 9, at 191.
150. Fredland, supra note 70, at 188.
151. Henderson, supra note 147; see also Fredland, supra note 70, at 188.
152. Henderson, supra note 147; see also Bailey, supra note 5.
153. Henderson, supra note 147; see also MCHUGHEN, supra note 9, at 14143; Bailey, supra note 5.
154. Fredland, supra note 70, at 188.
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bringing lawsuits.' 55 One campaign involved trying to get America's top chefs to
boycott GM vegetables. 56  This anti-biotechnology activism is truly a global
phenomenon. France's Jose Bose is perhaps the leading figure in Europe.' 57 In
India, Vandana Shiva is a particularly vocal critic of GM food, expressing outrage
that some badly needed food aid delivered to the storm-devastated Indian state of
Orissa in 1999 was genetically-modified.' 58 Activists declare that no science can
guarantee the safety of GM products, but this reasoning is unproductive because
one can never prove a negative. 159 Many activists are also adept at manipulating
the media and attracting the media's attention using all kinds of stunts.
160
Activists have been quite successful at linking the name "Frankenstein" with GM
foods, 16 1 and it has been a great way to generate fear. Books have been written
that appear solely aimed at discouraging the use of GM foods, and generating
155. PAUL R. GROSS & NORMA LEVITT, HIGHER SUPERSTITION: THE ACADEMIC LEFT AND ITS QUARRHSWIUH
SCIENCE 170 (1994).
156. Id
157. McNeil, supra note 121 ("Critics like Jose Bovd have become popular heroes for tearing up greenhouses flill
of test plants. Last week, a prosecutor asked for a 3-month sentence for Mr. Bovd for raiding an agronomy center in
Montpellier.").
158. Bailey, supra note 5.
159. Adler, supra note 54, at 777; see also MCHUGHEN, supra note 9, at 129 ("Opponents of GM technology
point out, correctly, that 'No developer of GMOs has assured us the GMO is risk-free!' They neglect to indicate
that developers of conventional products similarly decline to provide the same assurance for their non-GM
products."); id at 167 (explaining science cannot prove a negative); Weston, supra note 66, at 405 ("Having to
present evidence of absolute safety is an insurmountable burden."); GaryTaubes, The Cell-Phone Sam" Wh nFer
is the Opponent, Science Doesn't Stand a Chance, TECH. REV., Nov./Dec. 2000, at 117, 118 (In the context of
cellular phones: "This proving-a-negative problem comes with an important corollary: Experimental science is
also inherently incapable of achieving perfection. The experiment does not exist, nor will it ever, that can
unambiguously throw up zeros across the board simply because the phenomenon it has set out to study is
nonexistent.").
160. MCHUGHEN, supra note 9, at 173; see also Bailey, supra note 5, (explaining that such stunts have at time
involved considerable property damage); Kunich, supra note 48, at 814-15 (discussing "eco-terrorism").
161. The name "Frankenstein" and other variations on the theme have become almost synonymous with GMOs
and GM food. See KNEEN, supra note 15, at 172, 174, 175; Fredland, supra note 70, at 185, 187; John Hodgson,
GMO Roundup, 18 NAT. BIOTECH. 911 (2000) (commenting on Greenpeace's U.S. presidential candidate
"frankentony"); Mariai Burros, Labeling Foods with Designer Genes, N.Y. TIMES, Jan. 3, 2001, at F2;
Heppenheimer, supra note 61, at 12.
[For a] Quick Recipe for "Frankenfood Frenzy": Combine lots of emotionally-charged
doomsday rhetoric with a good amount of anti-capitalist sentiment. Add just a pinch of
scientific uncertainty about safety and you've created enough "Frankenfood" Frenzy to
serve the world. Caution: This dish can be ruined if contaminated by facts about the
health or environmental benefits of genetically modified foods.
"Frankenfood" Frenzy, REASONONLINE, at http://reason.com/bi/bi-gmf.shtml.
For an example of a highly-developed use of the Frankenstein metaphor in the context of GMOs, see generally John
S. Applegate, The Prometheus Principle: Using the Precautionary Principle to Harmonize the Regulation of
Genetically Modified Organisms, 9 IND. J. GLOBAL LEGAL STUD. 207 (2001).
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public alarm. 16 2 People have every right to express their opinions and to abhor
anything genetically-modified, but they do have alternatives to GM food. Organic
food is one of the most prominent alternatives.' 63  However, organic food
production has significant health and environmental risks of its own. 6 4
4. Spreading Knowledge, Understanding, and Acceptance
What needs to be done to improve public understanding? Better educating the
public about the science of GM crops and risk perception is the obvious answer,
but how one accomplishes this is not so clear. 165 One can explain the basics of
the science in a way that most people will be able to understand.' 66 The greater
acceptance of GM products in the U.S. has been stated to be positively correlated
with greater education and exposure of Americans to biotechnology. 167 However,
a survey in the UK actually showed greater opposition to biotechnology after
those surveyed had a training course on the subject. 168 Of course, how one asks
the question in a survey can bias the results.' 69 People arguably have a right not
to like biotechnology. Still, one's fears or dislike of GM foods are likely to be
much more complicated than a mere difference of opinion.
70
E. Perils and Promises of the Precautionary Principle in Light of GMO Fears
Even though the Protocol adopted "a risk assessment rather than the much
feared nonscientific criteria for decisionmaking,"' 17 1 its version of the
162. See, e.g., MARTIN TEITEL, PH.D& KIMBERLY A. WILSON, GENETICALLY ENGINEERED FOO. CHANGIG
THE NATURE OF NATURE (1999).
163. See generally McHughen, supra note 9, at 232-37 (discussing the viability of organic food as an alternative
to GMOs).
164. Id. at 233-36.
165. See id. at 3; Francer, supra note 49, at 305-08. See generally Sagar et al., supra note 125 (looking notjust
at matters of risk perception, but also how to address and respect the concerns of "stakeholders").
166. MCHUGHEN, supra note 9, at 3; see also Francer, supra note 49, at 306 (containing a challenge to
scientists to explain their findings in ways that the public can understand).
167. Francer, supra note 49, at 299.
168. MCHUGHEN, supra note 9, at 106.
169. Francer, supra note 49, at 299; see also Jane E. Brody, Gene Altered Foods: A Case Against Panic N.Y.
TIMES, Dec. 5, 2000, at F8 ("Ask American consumers whether they support the use ofbiotechnology in food and
agriculture and nearly 70 percent say they do. But ask the question another way, 'Do you approve of genetically
engineered (or genetically modified) foods?' and two-thirds say they do not.").
170. Cf MICHAEL SHERMER, WHY PEOPLE BELIEVE WEIRD THINGS: PSEUDOSCIENCE, SUPERSTITION, AND
OTHER CONFUSIONS OF OUR TIME 44-61 (1997) (explaining "How Thinking Goes Wrong: Twenty-fiveFallaies
That Lead Us to Believe Weird Things").
171. Gupta, supra note 7, at 30. .
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precautionary principle may still allow for nonscientific decisionmaking. 72 Some
people have already used the precautionary principle as grounds to ask
governments to ban all GM crops. 73 Critics at a recent conference felt that the
principle's nature left its exact application dependent on whoever the regulators
happen to be in any given situation. 74  A country would need to find,
conceivably, only a single scientist to issue a report claiming an environmental or
health risk to stop the importation of an LMO. 175 Additionally, views can vary
widely amongst scientists, especially along disciplinary lines, with molecular
biologists predicting less risk and ecologists being more conservative
(cautious). 7
6
Despite the potential for abuse, one should not dismiss the utility of the
precautionary principle in the context of GMOs. The value of the principle is that
it allows countries to deal with uncertainty, and to make decisions in the absence
of sufficient safety data on novel compounds and organisms. There is still a great
deal we do not know about genetic engineering and the new crop varieties and
other organisms that have been made using the technology. However, there are
critical differences between a process and the product that process creates.
Unfortunately mixing "process apples" with "product oranges" has lead to a great
deal of fear and confusion. For the precautionary principle to be truly effective, it
needs to be applied to all novel organisms, and not just to those developed using
modem biotechnology. The principle should be used even-handedly, or not be
used at all. To do otherwise would be to allow fear and possibly alternative
protectionist trade motives 177 to paralyze the introduction of GMOs and their
potential benefits.
172. See Miller & Conko, Science of Biotechnology, supra note 105, at 53; see also Hagen & Weiner, supra
note 7, at 711 (arguing that the Protocol's precautionary language would lead countries to restrict LMO imports
even "when the weight of scientific information suggests that the LMOs in question are safe").
173. Appell, supra note 93, at 18; see also Miller & Conko, Protocol's Illusionary Principl4 supra nm- 105,
at 360 ("The precautionary approach and precautionary principle are neologisms coined by opponentscftdrsrvog
who wish to rationalize banning things they don't like, such as gene splicing, cellular phones, oil exploration, and
carbon dioxide emissions.").
174. Appell, supra note 93, at 18.
175. Fredland, supra note 70, at 205; see also Adler, supra note 54, at 768-69 (arguing that the Protocol's
language "is sufficiently broad and tentative to justify almost any level of GMO regulation by individual
countries").
176. Thomas P. Redick et al., Private Legal Mechanisms for Regulating the Risks of Genetically Modified
Organisms: An Alternative Path within the Biosafety Protocol, 4 ENVTL. L. 1, 15 (1997).
177. ROYAL SOC'YOF CAN., supra note 71, at 196.
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IV. THE PROTOCOL'S "MAY CONTAIN" LANGUAGE AND THE PROBLEMS
ASSOCIATED WITH LABELING GMOs
Beyond the Protocol's precautionary language, the other main provision that
raises serious scientific policy issues is its labeling requirement. Article 18.2(a) of
the Protocol reads:
Each Party shall take measures to require that documentation
accompanying.... Living modified organisms that are intended
for direct use as food or feed, or for processing, clearly
identifies that they "may contain" living modified organisms and
are not intended for intentional introduction into the
environment, as well as a contact point for further information.
The Conference of the Parties serving as the meeting of the
Parties to this Protocol shall take a decision on the detailed
requirements for this purpose, including specification of their
identity and any unique identification, no later than two years
after the date of entry into force of this Protocol. 1
78
This "may contain" language is the result of a compromise between countries
who wanted no labeling and those that wanted documentation describing the
identity and unique attributes of all LMOs contained in a given shipment of
LMOs.179
While the Protocol does not cover LMOs once they are processed into
various food products, and so does not require the United States to label such
products for export,' 80 the "may contain" requirement still poses significant
problems. Additionally, while there is no present requirement for labeling of food
products that do not constitute LMOs, that could change in the near future. 18 1
Recent events suggest a turn toward more labeling. The EU-U.S. Biotechnology
Consultative Forum released a report calling for mandatory labeling of GM food at
the end of 2000.182 In early 2001, the FDA issued voluntary labeling
178. Protocol, supra note 6, art. 18, at 1035.
179. Gupta, supra note 7, at 29.
180. Cooper & Kilman, supra note 7.
181. Gupta, supra note 7, at 29.
182. Burros, supra note 161; Sarah Lueck & Scott Kilman, Gene-altered Food Needs Labels, Safety Reviews,
Committee Says, WALL ST. J., Dec.19, 2000, at B6.
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guidelines.183 Europe's extensive labeling requirements are another harbinger of
the future of labeling elsewhere.' 8
4
A. The Perils of Line-drawing
Central to the problem of labeling is deciding what should be labeled. The
issue of what should be labeled returns us to the theme of why we should label
products that involved biotechnology in their production, when biotechnology is
just one of many technologies available for producing new crop varieties.185 The
first step in examining the GM labeling issue will be to look at the perils of
drawing lines between genetic engineering and all other techniques.
1. Scapegoating the Rookie
One of the problems with drawing a line between biotechnology and
"conventionarl 86  breeding technologies is the sheer number of such
technologies. 87 If people are going to regulate GMOs, they should be regulating
other processes as well. 188 A sound biosafety mechanism should focus on risks
from any source and not just new sources. 18 9
GM crops are subject to a high degree of safety scrutiny compared to these
other techniques, even though some of these techniques potentially involve much
greater risks.' 90 The technologies include mutation breeding. Unlike genetic
engineering, with mutational breeding scientists do not know what genetic
changes have been made and have little or no knowledge at the molecular level of
the apparent novel characteristics of a novel variety.' 91 Even so, extrapolating
183. Lueck, supra note 78. But see Scott Kilman, FDA Warns of Misleading Labels On Genetic Modification
in Foods, WALL ST. J., Dec. 20, 2001, at B9 (It remains unclear what language food companies are permitted to
use to say that they have avoided the use of biotechnology in their products.).
184. For an overview of biotechnology regulation in the European Union, see Francer, supra note 49, at 277-0;,
Teel, supra note 48, at 667-77. The precautionary principle is a central and motivating force in Europe. See
Francer, supra note 49, at 278; Gupta, supra note 7, at 25-26. Just a few days after the Protocol was reached in
Montreal, the European Union issued a communication describing how it will apply the precautionary principle.
John Hodgson, Biosafety Rules Get Thumbs Up, 18 NAT. BIOTECH. 253 (2000); see also Gupta, supra ne 7, at
26.
185. See MCHUGHEN, supra note 9, at 71.
186. See id. at 62-70 (giving an overview and description of conventional crop breeding techniques).
187. Id. at 71.
188. See id
189. See id
190. See id.
191. ld
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from knowledge at the molecular level to the ecological level is difficult. 192
Nevertheless, if crops derived using the potentially risky technique of mutational
breeding are assumed safe, then why not crops derived using the much more
precise science of biotechnology?'
93
In some sense, one could say that all modem foods are "genetically
modified," albeit not always using modem biotechnology. 194 The corn of today,
genetically modified or not, is so removed from its "natural" ancestor that its
origins were disputed until modem genetic analyses became available.' 95 One can
also describe the products of modem biotechnology as not fundamentally
different from conventional methods, because conventional methods have been
used to move genes across species and even genera to produce crops that have
been on the market for decades.'
96
Others believe that modem biotechnology really is different, and there are
some strong arguments in their favor. These arguments hinge on both
quantitative and qualitative differences between genetic engineering and other
techniques.197 First, there are quantitative issues. Biotechnology makes possible
a large number of organisms, potentially much more than using traditional
techniques. 198  The collective impact of these numbers combined with the
difficulty of predicting their effects presents problems for risk assessment. 199
The quantitative aspects are not limited to the number of possible organisms; they
are also related to the enhanced speed with which they can be developed.2 °°
Second, there are qualitative issues in that not only are there a large number of
possible varieties, but also a large number of kinds of varieties. 20 ' That is, genetic
engineering allows genes to be added to an organism not just from its relatives,
but also from almost any other organism. 202 Another qualitative concern is that a
gene inserted through genetic engineering tends to be inserted randomly into the
192. See Schweizer, supra note 7, at 583-84.
193. MCHUGHEN, supra note 9, at 71. See Frederick H. Degnan, The Food Label and the Right-to-Know,52
FOOD & DRUG L.J. 49 (1997); see, e.g., Saigo, supra note 7, at 784; see also NAT'L ACAD. OF So., ssanote 1,
at 15 (for support of the "precision" argument).
194. Beales, supra note 84, at 107.
195. Id. at 107-08.
196. Id. at 105-06; see also Degnan, supra note 193, at 49 (revealing that the FDA shares this view); ROYAL
SOC'Y OF CAN., supra note 71, at 221 (revealing that Canada shares the view as wel ).
197. Winn, supra note 97, at 671; Wolfenbarger & Phifer, supra note 55, at 2092.
198. Wolfenbarger & Phifer, supra note 55, at 2092.
199. See id.
200. See Winn, supra note 97, at 671.
201. See id.; Wolfenbarger & Phifer, supra note 55, at 2092.
202. See Winn, supra note 97, at 671; Wolfenbarger & Phifer, supra note 55, at 2092.
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recipient organism's genome. There is also a related uncertainty of how the
introduced gene will interact with other genes in the organism.2 °4
There are then clearly problems that are unique to genetic engineering. Even
so, any process has unique risks as well as benefits. Genetic engineering can be
thought of as a set of tools, which allows one to move DNA with a level of
precision and control never before possible. Whether genetic engineering does
harm or not depends on how one uses it. Looking at genetic engineering as a set
of tools, a hammer can provide a useful analogy. One can use a hammer as a
bludgeon, but one can use the same hammer to build a house. Do we ban or
regulate hammers because of the former? Of course not.20 5 Similarly, singling
out crops produced using genetic engineering is largely counterproductive. This
kind of discrimination can be quite costly to consumers (in respect to labeling see
infra), especially in the Third World, as will be discussed in part V.
2. Rational Labeling: The FDA's Approach
The FDA has never considered the method of crop development to be the
type of information that should be listed on a product. 20 6  "[A]n implicit
component of the policy [of the FDA] is the fact that foods developed through
biotechnology are not inherently dangerous and should be regulated like ordinary
foods unless a new plant variety differs from its traditional counterpart to such an
extent that the common or usual name no longer applies, or unless it presents a
safety issue about which consumers must be informed., 20 7  This idea is also
known as "substantial equivalence., 20 8 While the transfer of a gene could cause
203. See Winn, supra note 97, at 671.
204. Id.
205. This type of analogy admittedly has its limitations. What about fire? Nuclear power? These technologies
can be used for good and evil, we certainly do regulate them, and in some situations ban them. However, the key
is "in some situations." That is, we should be focused on applications. We should be wary in making rash
generalizations about technologies. For an example of a source comparing biotechnology to a set a tools, see
Heppenheimer, supra note 61, at 10 ("Between 1967 and 1971, investigators developed a biochemical tool kit to
accomplish [the production of GMOsI, with the tools taking the form of specialized enzymes."). See also
McHUGHEN, supra note 9, at 46 (using "tools" to describe new genetic techniques); Id. at 70 (using word
"toolbox").
206. Degnan, supra note 193, at 55; Fred H. Degnan, Biotechnology and the Food Label.- A Legal Perspective,
55 FOOD & DRUG L.J. 301 (2000). The FDA does consider conventional methods of genetic engineering
techniques to be proper subject matter for labeling. Id. Since the agency views genetic engineering techniques as
simply extensions of traditional methods at the molecular level, it sees no need to label GM foods. Idat33Z. B&t
see Winn, supra note 97, at 685 (arguing "that genetic engineering is situated uniquely, relative to processes such
as canning, freezing, pasteurization, traditional plant breeding, and others").
207. Degnan, supra note 193, at 55.
208. See ROYAL SOC'Y OF CAN., supra note 71, at 177-91.
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such problems, the FDA will only require labeling when a particular transfer is
shown to present such a problem. 20 9 The agency also stresses that the scientific
community recognizes that the use of genetic engineering in food products does
not give rise to unique risks or hazards.210
The FDA's policy toward labeling is a voluntary policy, but there have now
been proposed standards for those who wish to label GM food.2t' In 1992, the
Agency had announced that foods derived from GMOs would not be treated
differently from products derived from "traditionar' organisms. 21 2 However, in
early 2001, the Agency stated that what had previously been voluntary notification
prior to putting a new GM food on the market would now become mandatory.21 3
The Protocol's position on notification may have been partly responsible for this
trend.
B. The Product vs. Process Debate
Our "line-drawing" discussion started out as of one of biotechnology versus
all other technologies, but it now appears that the issue might be better
characterized as one of process versus product. Unacceptable risks characterize
certain GM products. However, those risks are dependent upon the nature of the
product-not the process used to develop that product.21 4 In other words, if the
product had been generated using conventional technologies, it would still carry
the same risks.21 5 All of this ties back into the discussion of the precautionary
principle. The lack of any significant unexpected or unusual results from the
process of genetic engineering over the last quarter century suggests that the
209. Degnan, supra note 193, at 55.
210. Id.; see also Miller & Conko, Science of Biotechnology, supra note 105, at 48 ("But none of the risks that
may be associated with gene-spliced organisms is inherent in the method of production, and certainly none is
unique to recombinant DNA manipulation.").
211. See Lueck, supra note 78. But see Kilman, supra note 183 (It remains unclear what language food
companies are permitted to use to say that they have avoided the use of biotechnology in their products.).
212. NOTTINGHAM, supra note 15, at 125.
213. Lueck, supra note 78; Michael F. Jacobson, Consumer Groups Shouldn't Reject Biotech, WALIST.J,.Jan
25, 2001, at A20.
214. MCHUGHEN, supra note 9, at 159. But cf KNEEN, supra note 15, at 121 (explaining that in the context of
meat processing, the safety of the product is assumed from the safety of the process).
215. MCHUGHEN, supra note 9, at 159; see also NOTTINGHAM, supra note 15, at 145 (" In many cases there is
no scientific evidence to suggest that the methods of production using genetic engineering per se alter food
composition in a meaningful or uniform manner. The food industry understandably wants labeling to be on a
strictly logical and scientific basis.").
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process of genetic engineering survives the precautionary principle, but the same
cannot necessarily be said of all GM products. 2
16
The language of annex III suggests that the Protocol may take a product
approach: "Risk assessment should be carried out on a case-by-case basis. The
required information may vary in nature and level of detail from case to case,
depending on the living modified organism concerned, its intended use and the
likely potential receiving environment., 2 17 However, this case-by-case approach
only applies to LMOs. Why exclude organisms that were created using
conventional methods, and that can pose environmental and health risks?
The Bt-com of earlier discussion can be more precisely described as an
"input" crop. 21 8  Input crops are those designed for insect or herbicide
tolerance. 2' 9 They represent a benefit for farmers, but do not result in a product
that is significantly different for the consumer. 220  A label in such a case is not
very helpful. In the case of a "quality" crop, the GM crop results in an end
product with different characteristics, e.g., altered nutritional value. 221
Consequently, when a crop has been modified in ways that would affect its use, a
label is much more valuable.2 22 However, the important information is the "fact
of the difference, not the method used to produce the difference. ,223  Still, the
Codex Committee on Food Labelling (CCFL) of the Codex Alimentarius
216. MCHUGHEN, supra note 9, at 140; see also Heppenheimer, supra note 61, at 14 (Even in the early days of
biotechnology: "Despite extensive efforts to detect some evidence of actual or potential hazard, none has been
found.").
217. Protocol, supra note 6, annex. Ill, at 1045; see also Miller & Conko, Protocol's Illusionary Principle
supra note 105 ("Annex II contains a guide to what the protocol considers adequate risk assessment. It properly
focuses on the biological characteristics of the individual products, but leaves much discretion to regulators about
the framework for risk analysis.").
218. Beales, supra note 84, at 107.
219. Id.
220. Id.
221. Id.
222. See id. (The author discusses "input" crops where the genetic differences are essentially only of interest to
farmers. In the case of "quality" crops that limitation does not hold true because the differences should be of
interest to consumers as well as farmers.).
223. Id. at I ll. The U.S. Supreme Court agreed in a 1924 case regarding apple vinegar. See Goldman, supra
note 83, at 724 ("The misrepresentation was in respect of the vinegar itself, and did not relate to the method of
production merely. When considered independently of the product, the method of manufacture is not makial. lThe
[Food and Drugs Act of June 30, 1906] requires no disclosure concerning it." (quoting United States v. Ninety-fwe
Barrels (More or Less) Alleged Apple Cider Vinegar, 265 U.S. 438, 445 (1924)); see also Alliance for
Bio-lntegrity v. Shalala, 116 F. Supp. 2d 166, 35 n.10 (D. D.C. 2000) (citing the same 1924 case to show that the
manufacturing method is irrelevant.).
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Commission, the principal international body overseeing food labeling, is split on
whether to label based on product or process.224
The one instance where the FDA has required a process to appear on a label
is food irradiation. 225  This exception does in some sense prove the rule, as
irradiation can materially affect flavor, shelf-life, and other qualities that
consumers expect from their food.22 6 On the other hand, biotechnology or
genetic engineering is a neutral process. If one could point to one, albeit
theoretical, common danger of GM products, it would be the use of antibiotic
marker genes. As already mentioned, scientists can now remove antibiotic
marker genes from crops before they are commercially developed,22 7 and even if
they are not, the odds of such a gene being transferred in nature are
infinitesimal.228
C. The Segregation Nightmare
The Protocol requires that products "intended for direct use as food or feed,
or for processing '229 be "clearly" labeled that they "may contain" LMOs.23 °
Saying a product may contain something is hardly clear, and can actually be
deceptive.2 3' The main reason the "may contain" language appears is that GM
crops and non-GM crops are routinely mixed during the storage and shipment,
224. ROYAL SOC'Y OF CAN., supra note 71, at 221. Created nearly thirty years ago by two UN agencies, the
FAO and World Health Organization (WHO), the mission of the Codex Alimentarius is the establishment and
harmonization of food definitions and requirements, in part to facilitate trade. KNEEN, supra note 15, at 124-25;
see generally UNDERSTANDING THE CODEX ALIMENTARIUS, at
http://www.fao.org/docrep/w91l4e/w9l14e00.htm. Like the Protocol, the Codex is concerned with food safety.
See Francer, supra note 49, at 308; UNDERSTANDING THE CODEX ALIMENTARIUS, supra. The WTO, which as
has been discussed, may conflict with the Protocol, relies heavily upon the Codex. See infra Part 11; Francer,
supra note 49, at 309; Fredland, supra note 70, at 206; DAWKINS, supra note 78, at 37. Some critics have
complained that multinational food corporations have too much influence on the Codex. See id.; sKs'epustv
note 15, at 126.
225. See Degnan, supra note 206, at 306; Goldman, supra note 83, at 724; see also KNEEN, supra note 15, at
123 ("Irradiation obviously had the regulators stumped, so they categorized it as an additive to be approved (and
labeled) on a case-by-case basis.").
226. Degnan, supra note 206, at 306; Goldman, supra note 83, at 725.
227. NAT'L. ACAD. OF SC., supra note I, at 16.
228. McHUGHEN, supra note 9, at 185-86.
229. Protocol, supra note 6, art. 18, at 1035.
230. Id.
231. Beales, supra note 84, at 116 ("At worst, a mandated GMO label would be deceptive, if its absence from
products were to imply that the foods had not undergone genetic modifications at some point in their evolution.");
see also Saigo, supra note 7, at 814 (arguing that the "may contain" requirement may cause problems in the event
of an accidental release of LMOs, for "local authorities would have a difficult time identifying and managing the
release and its attendant risks").
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and separating them is all but impossible.2 32 In fact, crop varieties, regardless of
whether modem biotechnology or traditional techniques were used in their
development, are almost always mixed together during shipment, because grain is
sorted based on physical, not genetic characteristics.2 33
While testing for the presence of GMOs is possible, 234 segregation is
impractical largely due to cost.235  If segregation were required, the cost of
segregation could exceed the value of the product itself.236  Such segregation
would effectively prevent farmers from growing the same insect-resistant GM
crops that allowed them to grow food more economically in the first place.237
The "may contain" label seems like one way to avoid all these segregation
costs, because crops would not have to be completely segregated. Unfortunately,
the patent uncertainty of a "may contain" label ends up making the label
practically meaningless. 238  Especially in the U.S., such labeling would be
ubiquitous, as all products containing com or soy would end up being labeled.239
Additionally, as the FDA's policy reflects, statements that are "not technically
false or which may be literally true" can still cause deception.2 4 ° Some
jurisdictions, including the UK, impose fines for failing to label a GM product as
such. 24 1  However, there is no penalty for putting a "may contain" label on
232. McHUGHEN, supra note 9, at 78-79; see NOTTINGHAM, supra note 15, at 146; see also Beales, asrnloe
84, at 114-15; see also Fredland, supra note 70, at 191. But see KNEEN, supra note 15, at 145 ("The very same
companies that say biotech crops cannot be segregated are also engaged in developing genetically engineered
specialty crops whose value lies in the fact that their identity is preserved from seed through to delivery to the
processor ... ").
233. See McHUGHEN, supra note 9, at 78-79; see also Beales, supra note 84, at 114.
234. David Barboza, Caught in Headlights of the Biotech Debate: A Gene-testing Lab and Its Critics, N.Y.
TIMES, Oct. 11, 2000, at C l; see also Andrew Pollack, Labeling Genetically Altered Food Is Thorny Issue, N.Y.
TIMES, Sept. 26, 2000, at Al (elaborating on difficulty of testing for the presence of Starlink corn).
235. See MCHUGHEN, supra note 9, at 79; see also Beales, supra note 84, at 112-13 (arguing that the costs of
segregation should be born by those who care about having GM food; therefore, any labeling of GMOs should be
voluntary); see also Goldman, supra note 83, at 722 (giving more examples for the higher costs that would be
involved with separation); see also Feder, supra note 81, at CI (giving some information on the subject in the
context of the Starlink controversy).
236. NOTTINGHAM, supra note 15, at 146.
237. Id
238. MCHUGHEN, supra note 9, at 223-24.
239. Beales, supra note 84, at 116; see also Heppenheimer, supra note 61, at 16 ("Today one-fourth of the
nation's corn is genetically altered, while 70 percent of the processed food contains ingredients from transgenic
com, soybeans, and other plants.").
240. Degnan, supra note 193, at 59 (quoting Ninety-five Barrels, 265 U.S. at 442-43).
241. Alan McHughen, Uninformation and the Choice Paradox, 18 NATURE BIOTECH. 1018, 1019 (2000); sw
also Emma Dorey, EU Plans to Label and Trace GMOs, 19 NATURE BIOTECH. 795 (2001) (While not discussing
the use of fines, the author explains a labeling system for GMOs adopted by the European Commission in July
2001.).
2001]
INDIANA JOURNAL OF GLOBAL LEGAL STUDIES [Vol. 9:283
products that are not genetically modified.242 Since players in the food market do
not want to risk having to pay fines, they will just label everything as "may
contain" GM products, even if it costs them some sales.24 3
People may interpret the "may contain" label as meaning that food companies
do not care enough to find out, but because a product can be derived from a large
number of different sources, finding out may be a near impossible task.244 The
"may contain" label also has the power to inconvenience the consumer if one
wants to avoid GM foods; one will likely steer clear of foods that may not
actually contain any products of GMOs at all.245 In a more general sense, over-
labeling or special labeling of GM food may give the uninformed consumer the
impression that a genetically-engineered product is inherently unsafe.246 Such
labeling can even be in itself unsafe, if really important information, such as the
presence of an allergenic food substance, becomes overshadowed.247 Negative
labeling, i.e., ["]contains no GM product,["] is equally problematic, largely
because of the inability to prove a negative.
248
D. The "Right-to-Know" Nothing
One of the main arguments for mandatory labeling of GM products is the
consumer's "right-to-know.,, 2 4 9 This right-to-know concept and the existence of
mandatory labeling in Europe250 and elsewhere2 5 1 may be the principal reason for
242. McHughen, supra note 241, at 1019.
243. Id.
244. McHUGHEN, supra note 9, at 224.
245. See id. at 223-24.
246. See NOTTINGHAM, supra note 15, at 146; see also Degnan, supra note 193, at 59. The FDA is concerned
that claims by food companies that their products are free of GMOs will be interpreted by consumers to mean that
such products are healthier. Kilman, supra note 183. FDA officials are also concerned that certain marketers may
be attempting to exploit "the public's worries about an unfamiliar technology ... " Id
247. Beales, supra note 84, at 116.
248. MCHUGHEN, supra note 9, at 224-25. A recent study sponsored by the Wall Street Journal showed that
many products claiming to contain no GM ingredients, actually do. Patricia Callahan & Scott Kilman, Seedof
Doubt: Some Ingredients Are Genetically Modified, Despite Labels' Claims, WALL ST. J., Apr. 5, 2001, at Al;
see also Kilman, supra note 183 C'The FDA also doubts that food companies can make a non-GMO claim with
absolute certainty.").
249. See NOTTINGHAM, supra note 15, at 147-54; Goldman, supra note 83, at 720; Teel, supra nte48,659,
see also Francer, supra note 49, at 297 ("The Greenpeace World Wide Web site declares, 'We want natural food!
Consumers want real food and the right to know and to choose."'). For general background on the issue of right-
to-know, see Degnan, supra note 206. See also Degnan, supra note 193; Eli Kintish, Sticker Shock, NEW
REPUBLIC, Jan. 22, 2001, at 11, 12. "[R]epeated surveys show that the majority of U.S. consumes warttoknow
about the presence of genetically-modified ingredients, apparently so that they can choose whether to avoid them."
Kilman, supra note 183.
250. See Degnan, supra note 193, at 56-57.
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the "may contain" provision in the Protocol. But if "may contain" labels are
problematic in themselves, then labeling of products made from food
commodities labeled "may contain" LMOs is even more flawed. Yet, this kind of
labeling is what happens in countries mandating labeling of GM foods.252
The Protocol's approach toward labeling is troubling because the Protocol is
presumably designed for the safety of human health and the environment, not for
consumer preferences. Frederick Degnan's summary of the FDA food labeling
law is instructive here:
Congress, over decades of regulation of the food label, has
concluded consistently that the central purpose of the food
label--i.e., to meaningfully inform, warn, and instruct--mustbe
accomplishable.... Simply put, although consumer interest in
receiving information is important, consumer interest alone is
not enough to justify requiring that such information be included
in food labels.25 3
The FDA's position has been upheld in court.254
In September of 2000, the D.C. district court dismissed a case filed by the
Alliance for Bio-Integrity, other public interest groups, and religious groups
against the FDA over its 1992 policy statement on GM foods, discussed above
(Part IV A2). 255  The D.C. district court, among other holdings, accepted the
FDA's position that it was not required to label GM foods as a class solely on the
grounds of consumer demand or the process used.2 56 The plaintiffs included
religious leaders who claimed their religious freedoms were being violated,
because a lack of GM food labeling made it almost impossible for them to adhere
25 1. See Aaron J. Bouchie, Australia/NZ label GMfoods, 18 NAT. BIOTECH. 911 (2000) (giving information on
Australia and New Zealand's labeling standard, as well as those of other entities); see also Denise M. Lietz, A
Precautionary Tale: The International Trade Implications of Regulating Genetically Modified Foods in Australia
and New Zealand, 10 PAC. RIM L. & POL'Y J. 411 (2001) (providing background on labeling laws and policy in
Australia and New Zealand).
252. See, e.g., McHughen, supra note 241, at 1019.
253. Degnan, supra note 193, at 60.
254. See Shalala, 116 F. Supp. 2d at 166; Press Release, Food and Drug Administration, U.S. District Court
Dismisses Genetically Engineered Food Lawsuit Against FDA (Oct. 6, 2000) [hereinafter Press Release], awiiahke
at http://www.fda.gov/bbs/topics/ANSWERS/ANS01043.html.
255. Press Release, supra note 254.
256. Id.; see also Shalala, 116 F. Supp. 2d at 178 n.8 ("Thus, without a determination that, as a classrDNA
derived food pose inherent risks or safety consequences to consumers, or differ in some material way from their
traditional counterparts, the FDA is without authority to mandate labeling."); id at 179 (Trlhe FDA lacks a basis
upon which it can legally mandate labeling, regardless of the level of consumer demand.").
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to their strict dietary laws. 2 7 The District Court found no violation of their right
to free exercise of religion.258 The FDA also had not violated the Religious
Freedom Restoration Act.259 People have the right to oppose GM foods on the
basis of religion, but they should have the burden of determining the source and
sanctity of their food.2 60  Religious preferences are a form of consumer
preference. Having the government label foods based on religious preferences
could lead to similar demands from different groups having their own personal
preferences.26' When one extrapolates such demands to a global level, on which
the Protocol operates, trade in foodstuffs would arguably become debilitated.
Mandatory labeling of GM products not only fails to inform, it can actually
reduce consumer choices.262 And, tying in the process versus product debate,
the right to know argument is in no way limited to genetic engineering. If
consumers have a right-to-know about one process, genetic engineering, why not
others?263 Still, if people do not understand what is on the label, it is hard to
justify putting that information on the label, absent some reason other than simply
personal preference.264 Alan McHughen has proposed a public database of all
food products and their processes as an alternative to labeling.2 65  Much
information on GMOs is already available to the public in Europe, the U.S. and
Canada. 2 6 6 The Protocol's Clearing-House 67 also responds in part to this call.
If GM labeling is going to be allowed at all, both internationally and
domestically, then it ought to be done on a voluntary rather than a mandatory
basis. 268 Voluntary labeling makes sense from an economic perspective, because
those who are interested in the information will pay for the added costs involved
with labeling, and those who do not value the information will not have to pay for
257. Teel, supra note 48, at 660-61.
258. Shalala, 116 F. Supp. 2d at 179-80.
259. Id. at 181.
260. MCHUGHEN, supra note 9, at 220.
261. Id.
262. McHughen, supra note 241, at 1018. See generally Goldman, supra note 83.
263. See Beales, supra note 84, at 109.
264. See MCHUGHEN, supra note 9, at 209-11 (using sodium benzoate as an example of an ingredient listing that
most people do not know anything about, so this information does not help the consumer. Sodium benzoate
harms rats in relatively low amounts, but is still considered to be one of the safer food preservatives.).
265. Id. at 241-42; see also NAT'L. ACAD. OF SCI., supra note 1, at 15 (arguing for a public database containing
information on allergens and natural toxins).
266. McHUGHEN, supra note 9, at 242.
267. Protocol, supra note 6, art. 20, at 1036-37.
268. See Goldman, supra note 83, at 723; see also ROYAL SOC'YOF CAN., supra note 71, at 226-27(eading
this same conclusion). See generally Degnan, supra note 193, at 59-60.
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it.2 6 9 In connection with the earlier discussion about GM products with "quality"
attributes, manufacturers may eventually want to label their GM goods as "value
added products. '2 70
While the Protocol by itself may hasten domestic labeling laws in the West,
consumer demand will be more of an impetus in developing countries, because of
the difficulty of implementing a labeling regime and the increased cost of food
products. 271 Nevertheless, the Protocol and GMOs in general stand to have a
substantial impact on the Third World.
V. THE IMPACT OF GMOs AND THE PROTOCOL ON DEVELOPING COUNTRIES
AND SUSTAINABLE DEVELOPMENT
Developing countries were actually the group that originally called for the
Protocol's creation,2 72 but it is as yet unclear whether it really serves their best
interests. The potential environmental and health benefits of GM crops in general
have already been discussed,2 73 and these benefits will arguably have the greatest
impact in developing countries. A recent National Academy of Sciences report
stresses the importance of GM crops in realizing sustainable development:
We conclude that steps must be taken to meet the urgent need
for sustainable practices in world agriculture if the demands of
an expanding world population are to be met without destroying
the environment or natural resource base. In particular, GM
technology, coupled with important developments in other areas,
should be used to increase the production of main food staples,
improve the efficiency of production, reduce the environmental
impact of agriculture, and provide access to food for small-scale
farmers.27 4
269. See Beales, supra note 84, at 112-13; Kintish, supra note 249, at 12.
270. McHUGHEN, supra note 9, at 229; see also Beales, supra note 84, at 113 (arguing that voluntary labeling
provides an ongoing market test to determine if consumers actually care about a given food characteristic).
271. Gupta, supra note 7, at 29-30.
272. Id. at 24.
273. See infra Part II.B; see also GOKLANY, supra note 54, at 15 (showing a table of health benefits-problems
especially affecting the third world).
274. NAT'L. ACAD. OF SC., supra note I, at 6; see also Kinderlerer, supra note 4, at 563 (arguing that
biotechnology will likely be needed to obtain sustainability); Borlaug, supra note 5 (arguing that we will be able
to feed world in 2025 without a significant impact on the environment, only if we use biotechnology).
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Despite the promises of GM crops for achieving goals of sustainability in
developing countries, there are also negatives, and GM crops may, in some
respects, make things worse. Transgenic crops can be more expensive for Third
World countries when all costs are considered.275 People go hungry not
necessarily because of a lack of food, but because of a lack of access to food.276
In their July 2000 report, the National Academy of Sciences estimated that there
are about 800 million people or eighteen percent of the developing world who do
not have access to sufficient food.277 Nevertheless, GM crops are not
necessarily antithetical to improving access to food.278
A. A New Imperialism?
To some developing countries, the wave of GM crops may seem like a new
tide of imperialism. One critic of GM crops has remarked:
We should not be fooled into believing that the intent of
engineering the seed and occupying the land is to feed the world
or save the environment; it is to gain control and create
dependency. Like all imperial and colonial endeavors, its
purpose is to gain the ability to exploit the resources of the
colonized area and people for the benefit of the imperial powers.
The new twist is that the imperial powers are now
corporations, not states."'
However, developing countries can also view restrictions on GM foods by
developed countries, and especially by the EU, as imperialistic and harmful,
considering the promise these foods have in alleviating hunger in developing
countries.2 8 °
275. NOTTINGHAM, supra note 15, at 164.
276. Id. at 157; see also KNEEN, supra note 15, at 25 (pointing to a World Bank report that stated that if the
world's food had been evenly distributed in 1994, there would have been more than enough food for everybody to
have had an adequate daily diet).
277. NAT'L. ACAD. OF SC., supra note 1, at 3.
278. Id. at 4.
279. KNEEN, supra note 15, at 180; see also Sean D. Murphy, Biotechnology and International Law, 42
HARV. INT'L L.J. 47, 66 (2001) (discussing "bio-colonialism" and the exploitation of developing 0aX huies tl
licensing fees).
280. See Shane Wright, Poor Nations "Losers " In GM Food Ban, THE AGE (AUSTL.), Jan. 20, 2001, awek
at http://www.biotechknowledge.com/showlib.php3?uid=4388&countty=us; Andrew Pollack, A Food Fight for
High Stakes, N.Y. TIMES, Feb. 4, 2001, § 4, at 6 ("Are [the critics of biotechnology] so against it that they are
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1. Big Agriculture in the Third World
Large international agriculture and biotechnology companies want to grow
transgenic crops in the Third World that are often not geared to the domestic
needs of these countries' peoples.281 Transgenic plants in industrialized countries
can be engineered to yield products that were once derived from products made
and crops produced in developing countries, leading to a loss of jobs.282 Some
believe that GM crops share the same philosophy as that of the Green
Revolution-high-input and high-yield, which necessitates the use of great
quantities of fertilizer causing further environmental problems.283 Norman
Borlaug, "father of the Green Revolution" of the 1960s and 1970s, has been
criticized for his strong support of the new revolution of biotechnology.2 84
Nevertheless, he is not alone in his support for this "new green revolution."
285
Nor should he be alone, considering the numerous benefits of GMOs.
Just to survive, biotechnology companies may need to start with lucrative
crops designed for the developed world. 28 6 Eventually they should be able to turn
more attention to developing countries, and there are already products in the
287GM cosaebigdvlpdt tpipeline that could help these countries. GM crops are being developed that
produce vaccines that ordinarily would be difficult to transport in developing
willing to see people die? Indeed, the critics, most of whom live in wealthy countries, are increasingly being
called imperialists for opposing a technology that could be used to develop improved crops for poor nations."); sw
also Hans Komberg, Food Fights Can't Feed the Hungry, BOSTON GLOBE, Aug. 21, 2001, at A19; Channapatna
S. Prakash, A Gene Revolution, ASIAWEEK, July 20, 2001, at 17 ("Asians must be on gdaragainstthe luxuriesof
the radical environmental movement-an unwanted export from its former colonial rulers.").
281. NOTTINGHAM, supra note 15, at 158-59. But see id at 159 (explaining that Monsanto does have a joint
relationship with Kenya with the goal of using genetic engineering to improve the cassava).
282. See id at 165-68; see also DAWKINS, supra note 78, at 42-43 (making a similar argument about production
and job losses in the Third World).
283. See NOTTINGHAM, supra note 15, at 162; see also DAWKINS, supra note 78, at 44-46 (summarizing and
giving examples of the ills that the Green Revolution has allegedly caused).
284. KNEEN, supra note 15, at 22-23. But see Borlaug, supra note 5 ("The citizens of affluent nations may be
able to pay more fBr food produced by 'natural' or 'organic' methods. The chronically undernourished people of
impoverished nations cannot They also cannot afford to have the promise of new agricultural technology nipped in
the bud, as many antibiotechnology activists wish.").
285. See Kinderlerer, supra note 4, at 557. But see Heppenheimer, supra note 61, at 16 (stating that GM crops
have yet to measure up in importance to the hybrid com of the Green Revolution). See generally RICHARD
MANNING, FOOD'S FRONTIER: THE NEXT GREEN REVOLUTION (2000) (giving a survey of how biotechnology is
and will improve agriculture in developing countries).
286. NOTTINGHAM, supra note 15, at 160; cf DAWKINS, supra note 78, at 30 (arguing that despite claiming
that they will feed the hungry, the biotechnology industry has focused its research on products that will bring
immediate benefits to themselves).
287. See NOTTINGHAM, supra note 15, at 160.
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countries. 288 "Golden rice" has been developed that is engineered to produce
Vitamin A, which will help prevent blindness in areas where this nutrient has
traditionally been deficient in peoples' diets.289
2. Intellectual Property Issues for the Third World
Intellectual property rights are one way that developed countries and their
companies exert control over the Third World.29° Industrialized nations own
ninety-seven percent of all the world's patents, and people or corporations based
in these nations own more than eighty percent of the patents granted in
developing countries.2 9 1  "Terminator technology" and related "genetic use
restriction technologies" (GURT) are one of the more controversial aspects of
intellectual property rights relating to GM crops.292 This technology would allow
biotech companies to produce sterile seeds, i.e., seeds that would allow farmers
to grow one generation of crops, but the resulting plants would be sterile.293
Variations on this technology would allow farmers to grow seeds or have the
plants express particular traits only if they paid the company who developed the
seed to trigger these events.294
Terminator technology is a special concern because some 1.4 billion people
rely on farm-saved seed.295 These people may not be able to afford to buy seeds
and the triggering chemicals needed to gain their full benefits.296 Such seeds
would prevent farmers from doing their own hybrid breeding, and unintentional
hybridization with their existing crop varieties could render those crops sterile.297
However, these problems are inconsequential if farmers do not buy the seeds to
begin with, and they will have no incentive to do so if the biotech companies fail
to market them correctly.298 Most importantly, Monsanto, the company who
288. See Langridge, supra note 1; NAT'L. ACAD. OF SCI., supra note I, at 12-13.
289. See GOKLANY, supra note 54, at 14; Press Release, supra note 61.
290. See generally NAT'L. ACAD. OF SCI., supra note 1, at 29-34.
291. Sagar et al., supra note 125, at 3.
292. See MCHUGHEN, supra note 9, at 192-93; NAT'L. ACAD. OF SCI., supra note 1, at 32-34; Saigo, supra
note 7, at 789; Barnaby J. Feder, Monsanto to Bar a Class of Seeds, N.Y. TIMES, Oct. 5, 1999, at Al.
293. See Feder, supra note 292, at AI.
294. See MCHuOGHEN, supra note 9, at 192-93.
295. Saigo, supra note 7, at 789.
296. Id.
297. Id.
298. See McHUGHEN, supra note 9, at 192.
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owns the technology, has announced that it will neither use technology itself nor
license it to others.
299
Some critics are concerned that a handful of companies control or will
control ownership of crops globally.3 °° While this is a legitimate concern, there
are and will be alternative sources for GM products instead of directly from
private companies. 30 1 One example is the International Service for the Acquisition
of Agri-Biotech Applications (ISAAA), a joint public -private venture that seeks to
make biotechnology applications available to the developing world.30 2
Additionally, both Farmer's Rights under the UN's Food and Agriculture
Organization FA0 30 3 and the Plant Breeder's Rights based on the Union for
Protection of New Varieties (UPOV) 30 4 represent intellectual property protection
regimes that are favorable to farmers, including those in developing countries.
B. The Protocol's Socio-economic Initiatives
While the Protocol does not specifically address intellectual property
concerns, it does help developing countries in other ways. As already mentioned,
developing countries are allowed to treat both LMOs destined for introduction into
the environment and those meant for direct use as food, feed, and processing
under the AIA. 305 Additionally, the Protocol specifically allows socio-economic
considerations to be taken into account in deciding whether to allow the
importation of a particular crop:
1. The Parties, in reaching a decision on import under this Protocol
or under its domestic measures implementing the Protocol, may
take into account, consistent with their international obligations,
299. See Feder, supra note 292.
300. See KNEEN, supra note 15, at 180; Saigo, supra note 7, at 796-97; see also Antonio Regaldo, Syngenta
Sequences the Genome of Rice, But Access to the Data Will Be Restricted, WALL ST. J., Jan. 26, 2001, at B6. See
generally John H. Barton & Peter Berger, Patenting Agriculture ISSUES IN SCI. & TECH., Summer 2001, at 43
(providing an overview of the global patent system on plants with suggestions on what to do with the oligopoly in
this area).
301. See MCHUGHEN, supra note 9, at 197; see also MANNING, supra note 285, at 33 (describing a
collaboration between Texas Tech and Ethiopia); Press Release, supra note 61 (reporting that "Golden Rice" will
be available from the International Rice Research Institute (IRRID, though the technology was a gift from industry.
The IRRI is a member of Consultative Group on International Agricultural Research (CGIAR)).
302. See ISAAA homepage, http://www.isaaa.org (last visited Oct. 14, 2001).
303. See DAWKINS, supra note 78, at 52.
304. See MCHUGHEN, supra note 9, at 244.
305. See infra Part I.B.
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socio-economic considerations arising from the impact of living
modified organisms on the conservation and sustainable use of
biological diversity, especially with regard to the value of
biological diversity to indigenous and local communities.
2. The Parties are encouraged to cooperate on research and
information exchange on any socio-economic impacts of living
modified organisms, especially on indigenous and local
communities.30 6
This allowance for socioeconomic considerations is potentially beneficial,
since indigenous and subsistence farmers can help to preserve biodiversity and
prevent genetic erosion.30 7 Other arguments include those already discussed,
most notably the replacement of goods derived from developing countries by GM
crops grown in developed countries.30 8 Unfortunately, while article 26 may be
well intentioned, it has the potential to cause more mischief even than the
precautionary principle. 30 9  The socio-economic provision effectively allows
countries to ban GM crops absent any scientific basis.310 As Alan McHughen
puts it, "Socio-economic aspects may well be important in the global debate, and
ought to be discussed in a suitable forum. But they negate the credibility of any
claim of 'science-based' procedures when they are inserted into the 'scientific'
risk assessment."
31 1
The uncertainty regarding the Protocol's relationship to other treaties,
including the WTO, means that it is not clear whether actions taken under article
26 would be consistent with other international obligations.3 12 What would
actually count as "socio-economic" is also unclear. 313 It might mean being able
to deny import of GM crops that would hurt the viability of domestic farmers, but
not the ability to turn away imports based purely on consumer sentiment.314 In
306. Protocol, supra note 6, art. 26, at 1039.
307. See Saigo, supra note 7, at 815.
308. See infra Part V.A.
309. Cf Lott, supra note 117.
310. Adler, supra note 54, at 771.
311. MCHUGHEN, supra note 9, at 144.
312. See Hagen & Weiner, supra note 7, at 708.
313. Id.
314. Id
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order to prevent exclusionary trade policies, the execution of article 26 will have
to be done cautiously.
3 1 5
C. Regulatory Weaknesses of Developing Countries
Another possible route for Third World exploitation is that these countries
often do not have the resources to establish effective regulations for policing GM
products.31 6 This deficiency could be used by multinational companies to sell
GM crops that would be prohibited elsewhere. 317 These countries often rely on
the exporting, developed country for regulatory review with the belief that if the
food is safe for their citizens, then it is good enough for theirs.3 18 The Protocol
seems to be a relative success in responding to these problems by giving
developing countries a voice and some protection, instead of being at the mercy
of the exporter. The agreement may also help these countries to develop their
own regulatory frameworks and capacity. 31 9  Article 22 expressly mandates
capacity-building for biosafety and financial assistance for implementation for
those countries that need such help. 320 However, one must also address a "brain
drain" of scientists from developing to developed countries.
32 1
VI. CONCLUSION: DON'T SHOOT THE MESSENGER.
GMOs are having and will have a dramatic, positive impact on world
agriculture. The Protocol, if properly implemented, has the potential to help
countries deal with the uncertainties and valid scientific concerns about GMOs
with regard to both human health and the environment. However, if abused, the
Protocol's precautionary provisions will likely short-circuit attempts to deliver the
benefits of GMOs to those who especially need them in developing countries.
315. Saigo, supra note 7, at 815.
316. See NOTTINGHAM, supra note 15, at 122-23; see also MCHUGHEN, supra note 9, at 156-57 (explaining
that since developing countries often lack the ability to establish appropriate regulations, they rely upon the
regulations of the exporter).
317. See NOTTINGHAM, supra note 15, at 123; see also Kinderlerer, supra note 4, at 564 (reporting that
developing countries are concerned as to whether companies are "dumping" GMOs on them because they cannot be
produced in Europe).
318. See MCHUGHEN, supra note 9, at 156-57.
319. See Gupta, supra note 7, at 31.
320. Protocol, supra note 6, art. 22, at 1038; cf NAT'L. ACAD. OFSCI., supra note I, at 2 ("Public health
regulatory systems need to be put in place in every country to identify and monitor any potential adverse human
health effects of tmnsgenic plants, as for any other new variety.").
321. See MANNING, supra note 285, at 125.
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Genetic engineering is like a messenger; it allows scientists to transfer genes from
one organism to another. The message or gene being sent may occasionally
result in a dangerous, novel organism. This danger derives not from the
messenger but from the particular message being sent. To have an effective
biosafety program, we must be concerned with individual products and not the
process used to generate them. Genetic engineering is but one process available
for generating novel organisms. The ultimate effect of the Protocol's narrow
focus on the process of genetic engineering remains to be determined. However,
ignoring novel organisms generated using other means leaves the door wide open
for potential harm to both human health and the environment. This myopia begs
the question: Does the Protocol really rest on biosafety, or is it a capitulation to
unwarranted fears of biotechnology?
